SEC T I ON

I

Overview
ANIMALS ARE U SED extensively in laboratory procedures, especially in biomedical
research, toxicity testing, and education.Estimates of current usage range from about
twenty million to seventy million animals per year in the U nited States alone. 1· 2
Many of these animals suffer severely. Some are deliberately sickened, injured, or
killed. Others suffer from neglect, ignorance, indifference, or outright cruelty.
No one wants to see animals suffer, regardless of one's opinion of the ethics of
animal research. For that reason alone, alternative methods should be developed to
replace the use of animals in laboratory procedures, to reduce animal use, or to
refine procedures so that pain or suffering is reduced. Replacement, reduction, and
refinement constitute the three Rs of the "alternatives approach" to laboratory
practices. The ultimate goal of this approach is the complete replacement of
laboratory animals with non-animal methods.

I. Typical housing of monkeys used in research
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The enormous toll in animal suffering is only one reason why the scientific and
lay communities should make every effort to explore research alternatives.Others are
the high cost and long duration of animal studies; potential inaccuracies in
extrapolating from animals to humans; the questionable value of animal-b ased
toxicity tests; and limitations on what can be learned from conventional animal
studies. 3 Scientists are recognizing that alternatives can be more effective and
practical than animal studies.
Five major types of alternatives have been developed:
(1) Human studies include clinical, epidemiological, and postmortem
investigations. For example, most substances known to cause cancer in humans have
been identified by epidemiological studies, not animal tests.
(2) In vitro techniques are used to study tissues, cells, or cellular components in
the controlled environment of laboratory containers. Living samples can be taken
from humans or animals. Even though animals may be used, one animal usually
provides enough tissue for numerous samples or the tissue can be propagated
indefinitely, serving study after study. In vitro techniques have been used in research
on AIDS (A cquired Immune Deficiency Syndrome) to isolate, identify, and
concentrate the AIDS virus and are now being used to screen drugs rapidly for
anti-AIDS virus activity.
(3) Mathematical models describe a biological system under study in
mathematical terms in order to predict novel features of that system. Existing
information about the system is used to design the model and make predictions. For
example, a model has been designed as a potential replacement for the animal-based
LD50 test, which estimates the dose of a substance needed to kill fifty percent of the
test animals. The model is designed to predict the lethal dose of untested chemicals
by comparing them to tested chemicals on the basis of chemical structure and
properties. Modeling can also identify the most fruitful avenue to pursue in an
ongoing study and thereby preclude fruitless experimentation.
(4) Less sentient organisms are used on the premise that some organisms have
less capacity for pain and suffering than do others. In general, invertebrates,
microorganisms, and plants are less sentient than vertebrates, and vertebrate embryos
are less sentient than the adults. The A mes test uses bacteria instead of animals to
detect cancer-causing chemicals.
(5) Physical/chemical techniques exploit instruments and chemical procedures,
not animals, to analyze the physical and chemical properties of drugs, body
chemicals, and other compounds. For example, diagnostic kits made of simple
materials and chemicals have replaced the use of rabbits in diagnosing pregnancy.
Physical/ chemical techniques can also reduce animal use if they perform their tasks
better than cruder methods and thereby require fewer animals per test.
Several other alternative techniques are available. These include (1) mechanical
models, which can be used in car-crash studies; (2) clinical studies of animals, which
can have carry-over effects in human medicine; and (3) computer-aided drug design,
which avoids the animal-based trial-and-error process of drug discovery
so prominent today.
Two noteworthy targets for alternative techniques are the LD50 test and the
Draize test, both of which have been widely criticized on scientific and humane
grounds. The LD50 test provides an assessment of a compound's poison potential. In
its most common form, the test involves force-feeding the compound to from 40 to
200 animals. Several modifications that require fewer than 20 animals have been
developed and, in some cases, have already been substituted for the traditional test.
Several promising alternatives do not involve LD50 testing at all; instead, they
invo!ve tech�iques such as in vitro methods, mathematical modeling, and use of less
sentient species.
The Draize test assesses a chemical's potential to damage the eye.Recently
developed modifications have the potential to refine the test (which now is
performed on rabbits) by providing anesthetics or to reduce the number of
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animals used per test fiom 6 to 18 to fewer than 6. Sev� ral substi� ute tests are
being developed using in vitro techniques and less sentient orgamsms (e.g.,
chicken embryos).
.
Despite these promising efforts, the traditional forms of the � r� 1�e an� 1050
_
tests stay in use, partly as a defense by industry agamst product-habihty claims,
partly the result of regulators' bureaucratic inertia, par �y thro�gh fear ?f c?nsumer
backlash, and partly because of inconsistencies among mternational guidelmes.
A lternatives can play a major role in education. Here are a few examples of how
they can be put to use:
.
( 1) The British system for training surgeons C3:fl replace the_ A m �ncan system of
practicing surgery on healthy animals. The former is an appr_ enuceship that_ stresses
clinical experience with humans (for medical students) or animals (for vetermary
students). In microsurgery, whose fine details make apprenticeship difficult, human
placentas may soon replace animals in training specialists.
.
(2)Computer-assisted mannequins that simulate the workings of the human
or animal body can demonstrate medical procedures, normal physiology, and
drug effects.
(3) Computer programs can simulate surgical procedures, drug effects, and
metabolic functions.
(4) Human cadavers can be used in virtually all aspects of me�ical training.
Progress in developing alterna_tiv� s in all ar�as _ of laboratory antmal use has been
encouraging, especially given the limited financ! al _ mvestment that has, so far, _been
forthcoming. Much of this progress has come withm the l ast ten years_, as public
concern for animals has provided greater incentive to develop alternatives_. Such
public concern can influence laboratory practices and benefit not only ammals, but
also scientific progress and public health.
Scientific innovations are making the direct study of humans (as opposed to the
study of "animal models" of humans) increasingly pract �cal and_ rewardi?g.
Conventional clinical studies are being supplemented with tn vitro studies of human
tissues or modeling studies using human data. Sophisticated new imaging
techniques, which can generate visual images of the body's inte�io� wi�out the need
for invasive procedures, are being used to study the human brain _ m acuon
harmlessly. In all of this research, the direct study of hu�ans o�viates th� need to
draw conclusions about humans from potentially misleadmg antmal studies.
In toxicity testing, recent emphasis on alternative approaches is generat �g a .
reevaluation of routine animal tests that, in some cases, are decades old. Testmg is
being brought out of the Dark Ages.
.
Unfortunately, despite clear evidence of the importance of alternative methods
in the history of biomedical research, the scientific community is generally lukew� m
to the alternatives approach. If the general public became more aw� e of _alternatives
and the promise they hold and communicated that awareness to their legislators
(who control most of the research funding), the scientific community would _ have_ to
take alternatives more seriously.Our hope is that, through efforts such as this guide,
we can·add to that awareness.
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A Closer Look
At Replacements, Reductions,
And Refmernents
THE ULTIMATE GOAL of the search for alternatives is the complete replacement of
animals in all laboratory procedures. While some procedures have been replaced
completely, replacement in all of biomedical research, testing, and education will
take many years.Reductions and refinements can be viewed as interim steps toward
the achievement of complete replacement.The practice of seeking replacements,
reductions, and refinements to animal experimentation is the "alternatives
approach." While some animal advocates include only replacements in this approach,
such a view is unnecessarily restrictive.
L et us look at the concepts of replacement, reduction, and refinement as they
can be applied in biomedical research, toxicity testing, and education.

Replacement

In biomedical research, an alternative technique known as tissue culture has
replaced, to a great extent, the use of animals in research on viruses, which cause a
variety of diseases.Tissue culture involves maintaining samples of living cells or
tissue from the body in laboratory containers. Studying viruses in tissue culture
enables researchers to concentrate the virus and to screen drugs for anti-viral activity.
Tissue-culture research on AIDS has isolated, identified, and concentrated the AIDS
virus.This technique is now being used to screen drugs quickly for anti-AIDS virus
activity.The results of some of these tests have been promising. 1
In toxicity testing, tissue culture may replace the use of animals in detecting
chemicals that cause photosensitivity reactions in humans.These chemicals cause
inflammation or tissue damage when ingested or applied to the skin, but only in the
presence of light. Existing tests for photosensitizing activity, including experiments
on animals and human volunteers, are inadequate. A recently developed alternative
uses a certain type of human blood cell. When these cells are incubated with
photosensitizing chemicals in the presence of light, their genetic activity is slowed.
The test monitors this activity.The test is quick, inexpensive, and reliable, and
yields results comparable to those of in vivo tests. 2
In education, computer-assisted mannequins are replacing some uses of animals
in medical training. A mannequin known as "Sim" is used to train anesthesiologists
at the U niversity of SouthernCalifornia MedicalCenter. Sim responds appropriately
to various procedures, such as intramuscular injections of certain drugs. Students can
draw blood, pass a catheter, practice intubation, and administer treatment for shock.
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II. Sim, a computen'zed mannequin that can replace animals
as subjects on which to practice medical procedures

In tests comparing students who practiced on the first prototype (Sim One) to a
group who trained on animals, the Sim One students consistently needed fewer tries
and less time to master intubation techniques. A new version of the mannequin is
now being mass-produced.
Reduction
Reduction alternatives are based on the premise that the number of animals
used in a procedure should be the minimum necessary to achieve the desired goal.
This premise can be applied to the design of experiments, as certain designs are
more economical in their use of animals than are others. 3Once a design has been
chosen, one needs to determine judiciously the number of animals to be used
in experimental and control groups. This planning can be aided by certain
statistical methods.
In biomedical research, the potential for reduction in the number of animals
used was illustrated in an unpublished analysis commissioned byThe Humane
Society of the United States. In a random sample of published research reports, in
nearly all cases, animal use could have been reduced from twenty-five percent to
more than seventy percent simply by a better choice of experimental design and
statistical tests. The quality of the results or their statistical validity would not have
been compromised.
In toxicity testing, the principle of reduction has been applied to the LD50 test,
used to estimate the lethal dose of a substance. This test traditionally involves from
40 to 200 animals. A modification of this test uses 6 to 10 animals to determine the
approximate lethal dose (ALD). In the ALD test, each animal is given a dose fifty
percent higher than the one given to the previous animal. This procedure continues
until a lethal (or fatal) dose is reached. The ALD test produces results that correlate
well with the traditionalL D50, yet it uses far fewer animals.4
In education, the number of animals used in high school and college dissections
can easily be reduced. Instead of each student dissecting a different animal, students
can view a few professionally dissected animals. These prepared specimens, known as
prosections, illustrate anatomy with a clarity that few student-prepared specimens
can match. Specially preserved and encased prosections can be used year after year,
sparing additional animal sacrifice.
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Refinement
Any modification in the care and use of laboratory animals is a refinement if it
reduces pain and suffering without compromising the outcome of the intended
laboratory project. Refinements can be beneficial from a scientific as well as humane
view because pain and suffering lead to behavioral, physiolofical, and anatomical
abnormalities that can distort the outcome of experiments. 5•
Refinements can yield the most immediate changes in the area of alternatives.
Living quarters can be made more comfortable, diet improved, and anesthetics and
analgesics administered more widely. The application of refinements is limited
largely by the imagination and motivation of experimenters and their technicians.
In biomedical research, some procedures used for the long-term restraint of
animals are being refined.Traditionally, scientists have immobilized animals for
weeks or months at a time to prevent them from pulling tubes from their bodies, to
facilitate the administration of frequently injected drugs, or for a variety of other
reasons. Restraining devices such as primate restraint chairs are being replaced by
various systems that allow freedom of movement, such as harnesses, tethers, and
biotelemetry systems (devices worn externally or implanted internally that transmit
information from the animal to a remote sensing device).
Several refinements have been proposed for toxicity tests. In Draize testing,
chemicals are instilled in the eyes of rabbits to assess their irritancy potential.
A dministering anesthetics and analgesics to relieve pain and antihistamines to reduce
the degree of eye damage would provide some relief to test animals. There has been
concern that these substances could distort test results or even be counterproductive
if anesthetics increased injury by inhibiting defensive responses such as blinking7 or if
antihistamines prolonged recovery from injury. 8 However, some anesthetics do not
have these drawbacks. 9
In education, the concept of refinement can be readily applied to laboratory
exercises in rat behavior that are common in introductory psychology and behavioral
biology courses. Some of these exercises demonstrate learning principles; some are
opportunities for students to categorize and observe behavior; and others provide
opportunities to practice using event recorders (devices that facilitate the recording of
behavioral information). Several procedures commonly associated with these exercises
are needlessly stressful.
For example, rats are highly social animals yet traditionally have been housed
singly. They are punished in order to aid learning, when the use of reward would
accomplish the same goal. They are deprived of food or water in order to enhance
the performance of some tasks. They are nocturnal animals accustomed to an
alternating day/ night cycle, yet are often kept in perpetual daylight. If they are
provided with a day/ night light cycle, they are forced to perform during the
daytime, when they would normally be inactive.
Refinements of these procedures are obvious. The animals should be housed
socially and kept in an environment with an alternating day/night cycle. The cycle
can be reversed so that the animals are active during the day, when classes are
usually held.Ideally, the animals should be observed under red light, which
facilitates student observations but does not distort nighttime activity. The rats
should be coaxed to learn by reward, not punishment, and their performance
enhanced through reward with favorite foods, not starvation.
Although the concepts of replacement, reduction, and refinement are distinct,
they can be combined in the same alternative procedure. A n example is the Limulus
A mebocyte Lysate (LAL) test, used to determine whether or not therapeutic solutions
will cause fever when administered intravenously to humans. The fever-producing
substance, or "pyrogen," is a toxic segment of the contaminating bacteria's surface.
The active ingredient in theL A L test is obtained from the blood of horseshoe crabs
that are caught in oceans, handled, and then released.Certain collected red blood
cells are burst to obtain a clear solution. This solution forms an easily recognized
opaque gel when mixed with a pyrogenic fluid.
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The LAL test was recently approved for use by the federal government and is
beginning to replace the older Pyrogen test. The latter uses a minimum of three
rabbits per test, each of which is administered experimental fluids that can be so
damaging that the animals have to be killed after the test. The LAL test is over 100
times more sensitive than the Pyrogen test and is also more economical, convenient,
and reliable. 10
The LAL test is a replacement for the Pyrogen test in that laboratory animals are
not required. The LA L-test involves a reduction in that one horseshoe crab
substitutes for several rabbits. It is a refinement in that the horseshoe crabs are only
temporarily disturbed in the wild, while the rabbits live in small cages and are
subjected to experimental procedures. The LAL test would be a refinement even if
horseshoe crabs were subjected to the same treatment as rabbits, because horseshoe
crabs, by virtue of a more primitive nervous system, probably are much less capable
of experiencing pain than are rabbits.

S EC TI O N

III

Promotion of the
Alternatives Concept: History
THE EARLIER DEFINITIONS of replacement, reduction, and refinement are slight
modifications of original definitions proposed byW.M.S. Russell and R.L. Burch
in 1959. 1 Russell and Burch labeled these principles the three Rs of humane
experimental technique. They also introduced the notions of fidelity and
discrimination, which are important in assessing the relative merits of using animals
and alternatives. In the context of biomedical research and testing, animals and
alternatives are used as surrogates or models for humans. A surrogate is a high
fidelity model to the extent that it resembles humans. In general, chimpanzees are
high fidelity models; bacteria are low fidelity models.
Models can have low fidelity but nevertheless be more useful than high fidelity
models in certain cases. This is because low fidelity models can be better
discriminators of the response under study. For example, horseshoe crabs in the LAL
test are replacing rabbits in the Pyrogen test. Horseshoe crabs happen to be better
than rabbits in discriminating the human fever response, despite the fact that
horseshoe crabs are lower fidelity models of humans.
A failure to consider a model's discrimination or sensitivity can lead to what
Russell and Burch labeled the "high fidelity fallacy."This fallacy ignores
discrimination by stating that, in general, models should have high fidelity. In
practice, this fallacy leads to excessive use of mammals, given their relatively high
fidelity to humans. This usage pattern can be seen in federally funded research
projects, discussed later. The high fidelity fallacy must be successfully repudiated
before alternatives will gain widespread acceptance.
Since publication ofRussell and Burch's book in 1959, several developments in
the promotion of the alternatives concept have occurred. A nimal protectionists have
established several organizations to finance the development of alternatives (T able I).
Perhaps the most prominent of these has been FRAME, which recently began a
coordinated effort to develop an alternative to the LD50 test. Other organizations are
promoting alternatives by offering cash prizes.
Since the 1970s, scientific conferences have been addressing the alternatives
concept, with mixed results. 2 In Canada, a gathering of toxicologists recommended
that the government and organizations supporting toxicological research "initiate and
fund research programs with the specific objective of developing and validating
non-animal models for use in the safety-evaluation process."3
G overnment action on alternatives began in Europe. In 1971, theCouncil of
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TABLE I
Some Sources of Financial Support for the Development of Alternatives

A. Organizations established to finance development of alternatives:
Organization

Location

American Fund for Alternatives
to Animals in Research

United States

Dr. HadwenTrust for Humane Research United Kingdom
FRAME (Fund for the Replacement
of Animals in MedicalExperiments)

United Kingdom

Humane ResearchTrust

United Kingdom

Irish AntiVivisection Society
Humane Research Fund

Ireland

Lawson Tait Trust

United Kingdom

Lord Dowding Fund

United Kingdom

B. Organizations offering monetary awards for alternatives development:
Organization
Doerenkamp & Zbinden Foundation
for Realistic Animal Protection in
Scientific Research
European Federation of
Pharmaceutical Industries Associations
Millenium G uild
World Society for the Protection
of Animals (Marchiz Animal
Welfare Award)

Area of Award
Education
Research or Testing
Testing
Research, Testing, orEducation

Europe called for the establishment of a documentation and information center for
alternatives and a facility to store tissue material to use in alternatives research.
Unfortunately, progress on this initiative has been slow.4 However, Holland, Sweden,
andWest G ermany have animal-research laws that favorably mention alternatives.
Sweden has even earmarked a small amount of money for alternatives research.>
Centers for alternatives research now exist in Switzerland,West G ermany, Canada,
and the United States. The centers are funded by industry, animal-protection
groups, and/or governments.
In the United States, several legislative initiatives on alternatives have been
advanced since 1980. The one that would have been the most far-reaching, if it had
passed, is the Research Modernization Act. Introduced in Congress in 1980, it would
have established a national center for alternatives research, redirected a certain
percentage of funds originally earmarked for live animal research into alternatives
research, and coordinated training programs in alternative methods.
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A legislative breakthrough came in 1985 with passage of the National Institutes
of Health (NIH) reauthorization bill, which contains provisions on alternatives.
Sponsored by Representative DougWalgren, these provisions call for NIH to
establish a plan for research into replacements, reductions, and refinements. The
plan must also include the development of such methods that have been found to be
valid and reliable and the training of scientists in their use.
Similar provisions are contained in amendments to the AnimalWelfare Act that
became law in December of 1985. 6The amendments were designated the "Improved
Standards for Laboratory Animals Act" and formerly constituted the Dole/Brown
bill, named for its sponsors, Senator Robert Dole and Representative G eorgeE.
Brown, Jr. The amendments mandate training for researchers and technicians in
alternative methods for research and testing. The amendments also call for the
creation of an information service at the National Agricultural Library in cooperation
with the National Library of Medicine. The service would provide information on
alternative research methods, including refinements such as the increased use of
anesthetics and analgesics, and methods to prevent unintended duplication of
animal experiments.
Alternatives in toxicity testing have been promoted by public campaigns against
the use of animals in the Draize test and the LD50 test. These campaigns are
spearheaded by large coalitions of animal-protection groups.
The Draize test is used extensively by the cosmetics industry. The anti-Draize
campaign singled out a major cosmetic company, Revlon, which, under pressure,
donated $750,000 in 1980 to Rockefeller University to develop an alternative to the
Draize test. The rest of the cosmetics industry, also under pressure, contributed one
million dollars in 1981 to establish the Center for Alternatives to AnimalTesting at
the Johns Hopkins University School of Public Health. The industry, through its
representative, the Cosmetic, Toiletry, and Fragrance Association, continues to
support the center and similar efforts at eight other institutions.
The target of the other campaign, the LD50 test, provides a rough estimate of
the toxicity of household products and other chemicals. Several federal agencies,
including the Food and Drug Administration, the Consumer Product Safety
Commission, and theEnvironmental Protection Agency, recently announced that
they no longer require the test for regulatory purposes. These agencies, however,
continue to accept LD50 results, and industry has been slow to discontinue the test
in the absence of an outright ban. A bill introduced in the 1985 Congress would
have required each federal agency actively to discourage use of the LD50 and to
recommend alternatives. (The bill may be reconsidered in the future.)
Other noteworthy events in the history of the alternatives approach were the
recent establishment of a fund for alternatives to animal use in research and teaching
at Texas A & M's College ofVeterinary Medicine and the establishment of the
United States' first professorship in humane ethics and animal welfare in 1985 at the
University of Pennsylvania School ofVeterinary Medicine. One of the goals of the
position will be to investigate alternatives to animal experimentation in
medical research. 7
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Current Uses of Animals in
Education, Toxicity Testing,
And Biomedical Research
THE A
LTERNATIVES APPROA
CH is a response to the use of animals in laboratory
procedures.Consequently, any thorough analysis of alternatives should discuss the
nature and scope of laboratory animal use. How many and what types of animals are
used and for what purposes? Unfortunately, such information is scanty and
conflicting. Even estimates of total laboratory animal use differ widely. Our
ignorance on these matters is a reflection of how complacent policymakers are toward
the use of animals in laboratories.
Andrew Rowan of theTufts University School of Veterinary Medicine has
discussed the shortcomings of existing estimates of laboratory animal use and derived
his own estimate from a variety of sources. 1 His figures are adopted here. He
estimated that seventy million animals are used per year in the United States alone.*
Nearly ninety percent are mice, rats, and other rodents, and the remainder, in
decreasing numerical importance, are birds, frogs, rabbits, dogs, ungulates, cats, and
primates.Excluded from these figures are invertebrate animals (e.g., fruit flies,
squid, and earthworms) because good estimates of numbers are lacking.
These millions of animals are used in three general activities: education, toxicity
testing, and biomedical research.
Education
Animals are used in a variety of procedures in biological, medical, and
veterinary education. Such procedures include destroying a frog's brain to test spinal
reflexes (performed in high school); dissecting cats, dogs, minks, and fish to learn
anatomy (performed in college); and practicing surgery on dogs obtained from
pounds (performed in medical and veterinary schools). Some high school students

*Rowan recent! y subdivided his estimate of animal use to reflect the fact that not all of the animals that
are bred for research or acquired by laboratories are actually used. 2 A certain percentage of these animals
die or are killed because they do not meet research specifications (e.g., age, sex, weight, general health).
Estimates of this figure range from a few percent of those acquired to almost fifty percent.l Rowan's
estimate of the number of animals actually used is twenty-five to thirty-five million animals per year. His
earlier estimate is retained here because it better reflects the toll that laboratory practices take on animals,
regardless of whether the animals are actually used.
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experiment on animals and display their results at science fairs . (For a comprehensive
discussion of the use of animals in high school biology classes and science fairs , see
Heather McGiffin and Nancy Brownley's Animals in Education .4 )
In the United States, an estimated 5 . 7 million animals are used every year in
education.) A detailed breakdown of this figure is unavailable, owing primarily to
the fact that educational and research uses of animals are often intermixed at the
undergraduate and graduate levels .
Figures are available for medical and veterinary schools. In the nation's 127
medical schools, a total of 36, 700 animals is used annually, with rats and dogs
making up seventy-one percent of this total (Table II). 6 The majority of these
animals are used in the teaching of surgery (fifty-one percent) and physiology
(sixteen percent). Most of the dogs (sixty-four percent) are used in these
two disciplines.

TABLE II
Estimated Animal Use in Medical Education in the United States, 1983-84•

Kind of Animal

Number Used

%

Pig
Primate
Guinea pig
Otherb

14,000
12,000
3,000
1 , 700
800
800
200
130
70
4,000

38.1
32.7
8.2
4.6
2.2
2.2
0.5
0.4
0.2
10.9

TOTAL

36,700

100.0

Rat
Dog
Mouse
Rabbit
Cat
Hamster

•Estimate is based on an extrapolation of a survey of sixteen selected medical schools evenly distributed by
geographic region (Northeast, Midwest , South, or West), ownership (public or private), and research
expenditures (low, medium, or high).
binciudes frogs, sheep, and pigeon�.
SOURCE: Office of Technology Assessment , Alternatives to Animal Use in Research, Testing, and

Education (Washington, D.C.: OTA, 1986).

Most of the surveyed medical schools expressed regret over not being able to use
animals to a greater extent in education , often citing cost as a limiting factor.
Table III shows comparable data on the nation's veterinary schools.7 The census
includes only those animals that began an exercise alive and either died or were
killed during the course of the exercise. The census excludes animals purcksed as
cadavers (presumably because the carcasses were by-products of other industries);
those that were clinical patients; and those killed at the schools prior to laboratory
exercises. The latter exclusion is regrettable because, as a result, the numbers in
Table III underestimate the adverse impact of veterinary schools on live animals.
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TABLE ID
Estimated Animal Use in Veterinary Education in the United States, 1983-84•

Kind of Animal

Number Used

Dog
Mouse
Rat
Bird
Reptile
Sheep
Cat
Horse
Rabbit
Goat
Pig
Guinea pig
Cow
Otherb

8,020
2 , 180
2,083
1 , 323
433
423
414
378
195
194
140
111
649

48.2
13.1
12.5
7.9
2.6
2.5
2.5
2.3
1.2
1.2
0.8
0.7
0.7
3.5

16,655

100.1

112

TOTAL

%

•This census of all U.S. veterinary schools does not include privately owned or pet animals used for clinical
demonstrations, animals purchased as cadavers, or those subjected to euthanas_ia prior to the laborat?ry
exercise. It includes only those animals that began the course alive and then either died or were subiected
to euthanasia during the course of the laboratory session.
bJncludes fish, frogs, hamsters, and exotic species.
SOURCE: Office of Technology Assessment, Alternatives.

In the academic year 1983-84, 16,655 animals were used in veterinary
education. Dogs account for almost half, and mice, rats , and birds constitute most of
the remaining animals.
.
. .
Education provides fertile ground for the application of alternatives beca�se
many educational projects are repetitive exercises whose outcomes are know? m
advance. They are unrefined in that the students who conduct them have little
knowledge of surgery, anesthesia, experimental design, or the animals' ?eeds.
Educational uses of animals seem especially ripe for replacements that snnulate
exercises with the use of films, videotapes, computers, or mannequins.

Toxicity Testing
.
.
Toxicity tests are attempts to determme whether chemicals are safe for human
use and the limits under which hazardous chemicals can be used safely. Tests are
conducted on a variety of chemical and biological substance� , . including_ drugs,.
vaccines, food additives, cosmetics , household cleaners , pestmdes, and md_ustnal
_
chemicals. Test substances may be force-fed, inhaled, or apphe1 to the skin or eyes.
Routine testing of new drugs examines the general effects of a smgle d�se (ac1;1te
toxicity) or repeated doses (chronic toxicity), or sp�c�c effects, such as mductton of
_
cancer (carcinogenicity), genetic damage (mutagen1c1ty), and congen1tal
malformations (teratogenicity).
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Toxicity testing is an enormous enterprise in the U nited States. It involves an
esti_mated fourteen million animals per year.8The cost of testing a single substance
varies from about twenty thousand dollars (using a limited range of tests) to over one
million dollars for a comprehensive evaluation. 9
. In the U nited States, the feder� government plays a major role in toxicity
testt�g, both thro1:1gh laws that require or encourage testing and through guidelines
that mfluence tesung procedures. 10 The Food and Drug Administration (FDA)
over�e� s mos� tes �i�g. (?ther federal agencies that require animal testing, either
explmtly or tmplmtly, mclude theConsumer Product SafetyCommission, the
Department ofTransponation, and theEnvironmental Protection Agency. 1 1
Product testing is sometimes required for pre-market approval; more often, it is
simply implied by requirements for safe and effective products. Federal statutes
explicitly require animal testing in only a handful of instances, such as the Federal
Hazardous Substances Act (administered by theConsumer Product Safety
Commission) and the Hazardous MaterialsTransportation Act (administered by the
Department ofTransportation). 12
The status quo of toxicity testing is woefully inadequate. Animal tests are too
costly and time-consuming to protect the public adequately from hazardous
substances. A basic toxicity study may cost half a million dollars and take two years
to conduct.Consequently, only a few of the tens of thousands of commercially
important chemicals have been extensively tested and most have scarcely been tested
at all. u Furthermore, an estimated one thousand new chemicals enter the market
every year. 14 There simply are not enough skilled personnel to evaluate the flood of
new chemicals and the backlog of old chemicals, even if money were available. 1 )
Not only are the duration and cost of animal testing prompting public health
officials and toxicologists to consider alternatives, but so is the dubious value of
many animal tests. For example, physicians have severely criticized animal tests for
birth defects ("teratogenicity tests"). Their criticisms have been compiled by Dr.
Robert Sharpe of the Lord Dowding Fund for Humane Research. 16• 7 In the book
Drugs a_nd Pregnancy , physician P. Lewis of Hammersmith Hospital, London, wrote
that �ntmal teratogenicity tests are "virtually useless scientifically." Another
contrtbutor to the same book, physician D. Hawkins of theInstitute ofObstetrics
and G ynaecology wrote: "The great majority of perinatal toxicological studies seem to
be intended to convey medicolegal protection to the pharmaceutical houses and
political protection to the official regulatory bodies, rather than produce information
that might be of value in human therapeutics." Physician R. Smithells of the
U niversity of Leeds characterized the extensive battery of animal teratogenicity tests
as "more in the nature of a public relations exercise than a serious contribution to
drug safety." Physician R. Brent of Jefferson MedicalCollege has made
similar comments.
Dr. Smith ells also feared that animal teratogenicity tests might do more harm
than good by screening out new drugs that induced malformations in newborn
!aboratory animals but could prove therapeutically useful and non-teratogenic
m humans.
1

IV·

objective criteria exist to interpret animal data directly in terms of
human risk. 18
Despite the obvious need for alternatives to animal testing, their promotion is
not without impediments. National and international regulations that mandate
animal testing are often inflexible and slow to change.Even when regulations are
updated in one country, a company seeking to market its products internationally
may still conduct the same set of traditional animal tests in order to satisfy all
regulations simultaneously.Companies may also persist in conducting animal tests if
they view the tests as indispensable in defending themselves from product-liability
lawsuits. Also, animal testing tends to intensify in response to public outcry against
newly discovered instances of harmful drugs, hygenic products, and environmental
chemicals. The time has surely come to reevaluate current toxicity tests, rather than
intensify their usage.

Biomedical Research
Animals are used in biomedical research as "models" or surrogates of human
beings in order to understand the functioning of the healthy body; determine the
effects of diseases and trauma on the body; and discover remedies for disorders,
among other uses. Roughly fifty million animals per year are used in biomedical
research in the U nited States alone. 1 9The degree of their pain and suffering depends
on the details of their care and use. Many laboratory animals are housed alone in
small, barren cages. They are pan of a variety of experiments; perhaps the least
fortunate are those that are burned, frozen, poisoned, blinded, irradiated, crushed,
infected, or shot. Although anesthetics and analgesics are sometimes administered to
these animals, they do not provide total relief, as any dental patient knows.
Animal research is extensive and diverse enough to permit the fruitful
application of alternatives, especially reduction and refinement. The rapidity and
extent of this application will depend on financial backing and the imagination and
motivation of researchers, as well as their perceptions of outside pressure.Certain
impediments will have to be overcome, however. These include resistance to change
from the research community and from industries with a financial stake in continued
animal research, including suppliers of animals, cages, food, and antibiotics. Similar
considerations apply to the use of animals in education and toxicity testing.

The illogicality of the situation is demonstrated by the continued use of
well-established drugs which are known to be teratogenic in some
mammalian species (e.g. aspirin, penicillin/streptomycin, cortisone).
Conversely, a new drug which comes through its animal reproductive
studies with flying colours may nevertheless be teratogenic in man.
The situation is not much better in other areas of toxicity testing. According to
the International Agency for Research onCancer:
. . . At the present time, a correlation between carcinogenicity in animals
and possible human risk cannot be made on a scientific basis . . . . No
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III. This beagle was burned over a large portion of its body as part of
an experiment.
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What Are the
Alternatives?
THE SAME TYPES of alternatives can be used in both research and toxicity testing.
These alternatives are in various stages of development and span a wide variety of
procedures and systems, including human studies, in vitro techniques, mathematical
and computer modeling, use of less sentient organisms, and physical and chemical
techniques.We will look at each of these possibilities, then determine how they
apply to the Draize and LD50 tests.
Human Studies
Humans are already used extensively in research. For example, 400,000 to
800,000 patients a year are enrolled in organized clinical investigations of drugs and
other treatments in the U.S. 1 However, an even greater emphasis on human studies
could reduce the demand for laboratory animals. Sick or injured persons could be
studied to improve the diagnosis, treatment, and prevention of medical problems.
Healthy volunteers could be incorporated into these clinical studies as controls.
Healthy volunteers could also be useful in studies that focus on maintaining or
improving health, rather than on coping with medical problems.
A second way to conduct human research is to analyze information on large
numbers of people to uncover potential relationships between the incidence of
disease or injury and people's habits or environments, such as smoking, drinking,
and working in certain occupations. These epidemiological studies are helpful in
identifying probable causes of health problems. Similar studies are helpful in
identifying promoters of good health. These studies may not convincingly
demonstrate a cause-and-effect relationship in some cases; however, they are often
helpful in providing clues that focus future research efforts.
The remaining category of human research consists of postmortem studies of
cadavers donated to science. These studies are particularly useful in anatomical and
transplant research.Cadavers are also sources of transplantable organs.
Cadavers have far more potential in biomedical research than current usage
suggests.In fact, postmortem studies could revolutionize research, toxicity testing,
and education and thereby greatly reduce our reliance on laboratory animals. The
key, according to a physician2 and an educator and physician,3 is to use cadavers that
are brain-dead but whose physiological functions are sustained by artificial support
systems. Known as "neomorts," these cadavers resemble comatose patients but have
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been certified as legally dead.
Support systems are even now being used by the biomedical community to keep
cadavers functional for medical or scientific reasons. A recent example is that of an
Indiana woman who died as a result of a car accident but whose body was sustained
by artificial supports until her child could be born by cesarean section several weeks
later. Although practical problems currently make neomort technology too expensive
and complicated for widespread use, it is believed that these problems may be solved
in the near future. 4 Not so likely to be resolved readily, however, are the ethical and
moral considerations restraining such use .
Because the availability of neomorts will undoubtedly be limited, priorities for
their use will have to be established. Likewise, a variety of technical, ethical, and
legal issues will need to be resolved. 5 •6 Scientists believe that such a resolution will
usher in a new era in biomedicine and science.
A lthough the reported use �f neomorts has been limited for reasons indicated
above, an example of one study, as well as examples of more traditional human
research, is discussed below.
• Human research has played an important role in the development of artificial
heart implants. The first clinical implant of the so-called Jarvik-7 artificial heart was
performed in 1982 on BarneyClark. One of the researchers involved in this
operation remarked that more was learned from this single case than from all of their
preceding research, which included dozens of implants in animals. Even if this
remark is an exaggeration, it underscores the importance that researchers attach to
clinical trials.
Beyond its role in clinical testing of the Jarvik-7 heart, human research also
played an important but undervalued role in pre-clinical testing.While it is widely
known that the Jarvik-7 was extensively tested in animals, it is hardly known (much
less appreciated) that postmortem studies were also involved. Physicians at Temple
University implanted the Jarvik-7 heart in five brain-dead humans. They
experimented with three different surgical implant techniques. They wrote:
. . We
.
were confronted with the question of whether or not an artificial
heart successfully tested in calves would fit and function in man. But how
to proceed in man with some assurance of success? . . .Today it is possible to
test the functional capabilities of intrathoraic blood pumps in brain-dead
but hemodynamically stable human subjects at no risk, so that it is not
necessary to learn the fundamentals of fit and function in patients . . . .The
relatives of the deceased subjects have been extremely supportive of our
experiments. Their hope is that, through these studies, others may live
longer and more comfortably. 7
Although this neomort study was a follow-up of animal studies, the clear
implication of neomort research is that our reliance on laboratory animals will
be reduced.
• Recent progress in understanding A lzheimer's disease, or senile dementia,
stems from clinical and postmortem studies of Alzheimer's patients. A natomical and
biochemical studies were conducted on brains of deceased patients, small brain
biopsies, and cerebrospinal fluid from living patients.
• Most substances known to cause cancer in humans have been identified by
epidemiological studies rather than by carcinogen tests in animals.8These hazards
were identified primarily through occupational association.
• Treatments for drug overdose are being improved through clinical studies
conducted at hospital poison centers.9 These centers are designed so that patients can
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be studied while given emergency treatment. One such center was established at
G uy's Hospital inEngland, where researchers concluded :
Whilst the data from the animai studies required by regulatory bodies
provide some basic information of the mechanism of toxicity and relative
toxicity, it cannot be assumed that this information will be entirely relevant
for man. Furthermore, whilst these studies may give indications as to the
appropriate treatment for acute overdosage, they are unlikely to indicate
the efficacy of treatment. &penence gainedfrom a careful assessment of
patients suffering from acute overdosage of drugs is potentially much more
useful than that obtainedfrom animal tests. 10
• Epidemiological studies have linked genetic damage to a variety of factors,
including drugs, metals, industrial chemicals, radiation, tobacco smoke, and alcohol.
The evidence is particularly strong for vinyl chloride, alcohol, and tobacco - the
higher the dose, the greater the incidence of genetic damage. 1 1 G enetic damage was
assessed by monitoring chromosome breakage in certain blood cells.
Further evidence of the importance of human studies comes from an analysis of
Nobel Prizes awarded in medicine or physiology. These prestigious prizes are
awarded for outstanding contributions in basic and applied research. Seventy-two
prizes have been awarded from 1901 (the year the prizes were initiated) through
1985. Of these, twenty-two (thirty-one percent) involved human studies to some
degree, including ten (fourteen percent) projects that were wholly or primarily
conducted on humans.
Despite such accomplishments, not all human studies can be considered
alternatives to animal studies. Instead, many human studies are follow-ups of
research on animals. Researchers often turn to animals before conducting studies on
humans because of ethical and practical problems of studying humans directly.
However, findings from animal studies must be verified in humans because they
cannot be extrapolated to humans with great accuracy. G iven the uncertainties of
this extrapolation, follow-up research on humans can truly be regarded as
experimental and the human subjects regarded as the last in a series of
"guinea pigs."
Sophisticated new techniques are helping to overcome ethical and l?racti�al
restrictions that have limited the extent to which humans could be studied duectly,
without recourse to potentially misleading animal models. For example, remarkable
new "imaging" techniques, which can generate visual images of the body's interior
without the need for invasive procedures, are now being used to harmlessly study the
human brain in action. One such technique is positron emission tomography (PET):
tiny amounts of radioactive chemicals mark areas of interest in the brain, and a ��ain
scanner detects these chemicals and generates pictures or "scans" that show the hvmg
brain in action.
PET has recently been applied in the study of Parkinson's disease, which afflicts
400,000 A mericans, mostly the elderly. Sufferers exhibit tremor, muscle rigidity and
weakness, and a shuffling gait. PET scans were taken of the brains of volunteers who
were known to have used a synthetic form of heroin tainted with a brain-damaging
substance. The scans revealed Parkinson's-like damage to specific brain cells in the
absence of overt signs of the disease. Such signs have begun to appear in persons
who first used the heroin two years previously. These studies suggested that exposure
to similar toxic substances may predispose people to develop Parkinson's later in life,
when additional brain-cell loss occurs as a result of aging.
This application of PET scans to humans has sparked a revolution in the
understanding of Parkinson's, which has baffled physicians for _ more _than a century. 12
Such studies are pointing the way to human research on the d1agnos1s, treatment,
.
and prevention of th e d'1sease. H · 14
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In Vitro Techniques
There is virtually no field of biomedical research that has not been affected
by in vitro technology. 1 �
Some human and animal tissues can be removed from the body and studied in
vitro (literally, "in glass," i.e., in a laboratory container). In vitro alternatives can be
either replacements or reductions. If tissue samples are derived entirely from humans
(from biopsies, autopsies, and placentas), then the research is a replacement. If
animals are deliberately killed to obtain tissue samples, then the research is a
reduction because tissue from a single animal often is enough to substitute for
several animals. In vitro studies involving animal tissue can be replacements if the
tissue is propagated indefinitely, providing material for study after study.

IV. An example of a potential in vitro alternative to the Draize test:
it assesses the potential of chemicals to inhibit cell growth, which, for
at least one class of chemi cals, correlates well with ey e irritancy . Cells
are grown in each of the ninety -six wells, treated with test chemicals.
A reagent is then added that develops color in proportion to the
extent of cell -growth inhibition.

There are several in vitro techniques; they differ in the type of material being
cultured and the duration of the culturing. Subcellular fractions contain parts of cells
or the entire contents of disgorged cells. Short-term cellular systems contain cells and
tissues that are cultured less than twenty-four hours. These diverse systems contain
isolated cells suspended in a fluid medium, tissue derived from biopsies, "tissue
slices" from whole organs, or whole organs treated with special chemicals. Tissue
culture contains cells and tissues that are nurtured for at least twenty-four hours.
Tissue culture is a prominent part of current research in alternatives.L iving
tissue is cultured in a medium that supplies nutrients. More sophisticated culturing
schemes can better mimic the workings of the whole animal by supplying chemical
substances that regulate cell function, such as hormones. 1 6
Tissue culture includes cell culture and organ culture. In cell culture, a tissue
fragment is dissociated into its component cells. The first generation of these cells is
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a primary cell culture. If the cells grow and multiply indefinitely, a continuous cell
line is established.
In organ culture, the emphasis is not on the growth and reproduction of
isolated cells but rather on the maintenance of the tissue's three-dimensional
structure and function. Organ cultures are relatively short-lived and do not
propagate themselves, so fresh samples are needed each time cultures are set up. This
may necessitate killing animals. However, as in cell culture, many organ cultures
usually can be derived from one animal and hence these cultures qualify as
reduction alternatives.
The placenta is a readily available organ that can be studied in vitro after it is
discharged with the rest of the afterbirth.The placenta is a complex, multipurpose
organ that is highly susceptible to drugs and chemicals, which makes it a suitable
system for pharmacological and toxicological studies. Its potential as an alternative is
conveyed in the title of a recent book, Placenta - A Neglected Expen·mental
Animal. 17 A research program aimed at substituting placentas for animals in toxicity
testing is being coordinated at the University ofL ondon and financed by theL ord
Dowding Fund for Humane Research. 18
In vitro techniques have several advantages over in vivo techniques, that is,
studies of intact organisms. They enable tissue, cells, or subcellular components to be
studied apart from confounding influences of other body systems. Because chemicals
of interest can be added directly to the culture, much smaller amounts of chemicals
are needed. This sensitivity was the main reason why the National CancerInstitute
(NC
I) recently launched a $2.5 million screening program for anti-tumor agents. An
NC
I representative noted that "the materials that we are typically looking for are
trace constituents, so the in vivo model is inherently an insensitive one and we may
miss, in most cases, our most interesting lead. " 19 Cells to be cultured can first be
cloned to achieve genetic homogenicity or be manipulated in other desired ways and
then studied.
Although in vitro techniques are ideally suited to studying biological systems in
isolation, they can also be designed to reflect interactions between systems. For
example, tissue from one organ can be exposed to specific hormones produced by
other organs, or a potentially toxic chemical can be incubated with liver cells to
determine whether the liver detoxifies the chemical before it can exert any toxic
effect on other cells. Although in vitro systems can be made more complicated in
this way, the strengths of the in vitro approach are its simplicity and precision.
While it is true that in vitro studies are ill-suited to model complex systems and
hence will never fully replace in vivo studies, the converse is also true.
In vitro technology can be applied to study virtually any type of cells in the
body. The practical problem of not being able to grow specialized cells has now been
large! y solved. 20
Examples of in vitro procedures follow:
• TheL A
L test, described earlier, is an in vitro test that uses subcellular
components obtained from horseshoe crabs to determine whether intravenous fluids
will induce fever. This newly introduced test is already being conducted more than a
million times annually. 21
• A tissue-culture technique has been developed to standardize th� potency of
rabies vaccine. 22 This vaccine consists of a weakened, live form of the rabies virus.
The potency of each batch of vaccine must be standardized so that it is not too
strong or too weak. Potency is currently evaluated in anL D50 test on mice, but the
twenty-one- day test period makes this test impractical. Confounding factors, such as
unrelated deaths and differential susceptibility of animals to the virus, can increase
the variability in test results. The alternative, tissue-culture test is as sensitive as the
mouse test but takes only twenty-four hours to conduct. The basis for the test is a
sophisticated technique that involves fluorescent antibodies.When these antibodies

33

· A L T E R N A T IV E S ·
attach to their targets (in this case, cells infected with rabies virus), the resulting
complex is easily detected and quantified under a microscope, owing to the
antibody's fluorescence. The developer of the test recommends it as a replacement
for the mouse test.
• A new in vitro test for diagnosing infant botulism is at the threshold of
clinical application. Developed by M. Dezfulian of the Johns HopkinsCenter for
Alternatives to A nimal Testing, the test probably will replace the conventional test
for this disease, which requires up to 200 mice. Infant botulism results from a
chronic intestinal infection by bacteria, which produce a toxin that causes extensive
damage. It is now the most common form of botulism, outranking acute infection
from food poisoning.
The disease is diagnosed by culturing stool samples. In the conventional test, an
extract from this medium is injected into mice. It is fatal if the botulism toxin is
present. In the alternative test, the toxin is detected by an in vitro reaction with
antitoxin antibodies. In its present formulation, this procedure does use animals
(rabbits) to produce the antibodies. However, this step is fairly harmless and
produces enough antibody from one rabbit to substitute for hundreds of mice. The
alternative test has several advantages over the conventional test. The mouse bioassay
is generally considered to be cumbersome and inconvenient, while the alternative test
is easily carried out in routine clinical laboratories. Its results are obtained overnight,
in comparison to seven to fourteen days in the bioassay. The alternative test has the
added advantage of not being confounded by any lethal substances, other than the
botulism toxin, that might be present in stool. 2 3 In Dezfulian's testing,24 the new
procedure proved as effective - if not more so - than the mouse test.
• Tissue-culture techniques have reduced the demand for laboratory animals in
virus research. A nimals are no longer needed as living test tubes to culture viruses.
Tissue-culture techniques can also be used to screen substances for their potential as
antiviral drugs. For example, one pharmaceutical company used mice to screen for
antiviral drugs. The company later added a cell culture as a primary screen and organ
culture as a secondary screen and retained mice as a final screen. In 1963, the
company screened one thousand substances per year using approximately sixteen
thousand mice. Twelve years later, after adopting in vitro techniques, it screened
twenty-two times more substances per year using approximately one tenth the
number of mice! 25
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culture that have been of great value in characterizing molecular abnormalities
num_erous m�dical diseases. "28 Imaginative research such as this expands the sco�: of
in vitro studies beyond what was formerly attempted.
Mathematical and Computer Models
Modern approaches to biomedical research are increasingly incorporating the
language of mathematics into their descriptions of living systems. Mathematical
approaches are being applied in studies of all levels of biological organization, from
interactions among molecules to interactions among organisms. In these approaches,
existing information is used to describe the system under study in mathematical
terms. The resulting mathematical model usually is a simplified version of reality but
is, nonetheless, helpful in understanding complicated systems, especially those in
which several variables influence an outcome.
As an illustration, consider the outcome to be the degree to which various
chemicals are toxic. Toxicity is likely to be influenced by several factors, including
the size and shape of the chemicals' molecules, the presence of certain reactive
groups, the way reactive fragments are linked together, and the chemicals' affinity
for fats versus water. Each of these factors can be represented mathematically by one
or more variables or "parameters." In this example, toxicity would be modeled on
the basis of the chemicals' structure, composition, and physical/ chemical properties.
Toxicity data on already-tested compounds could be used to help predict the toxicity
of unknown compounds. Models such as these are known as structure/activity
relationships (SARs) because chemical structure is used to predict activity, in this
case, toxicity.
Once mathematical models are formulated, they must be verified to see if they
accurately reflect the relationship under study. In toxicity testing, this verification
procedure is known as validation. In the area of research, verification usually involves
a procedure known as simulation. In a simulation, one or more parameters in the
model is changed to determine if the response is similar to that seen in the living
system. If dissimilar responses are obtained, the model can be refined or entirely
reformulated. Because simulations usually are too complex to conduct by hand,
researchers often turn to computers.Computer simulations are useful not only in
validating models but also in suggesting new mechanisms and hypotheses for
further study.

• Tissue-culture techniques are at the forefront of basic research in
biomedicine, particularly in studies of the immune system. According to the
National A cademy of Sciences, "Major recent advances in our knowledge of the
immune system made possible by cell cultures would have been virtually impossible
to achieve in intact vertebrates."26The same report notes the following:
It is clear that the study of in vitro antibody responses has led to a major
portion of our understanding of immune system responses. Using an in
vitro system, one can make 200 to 400 cultures from a single mouse. If
these same studies were to be conducted in vivo, they would require 200 to
400 mice to achieve the same number of observations.

V. Computer modeling equipment used by Dr. James Walker in
physiology exercises that have traditionally been performed on
dogs. These two monitors show data in graphic and tabular form.

Cell-culture techniques have recently been applied to behavioral research in
studies of the biochemical basis of depression and mania. Human skin cells were
maintained in culture and assessed for their ability to bind to various
pharmacological agents. 27 The cultured cells of manic- depressives and their relatives
exhibited biochemical properties markedly different from the cells of persons without
a family history of manic depression. One commentator characterized this research as
"a step forward, applying to psychiatry the techniques of tissue sampling and cell

Modeling is now an intefral part of research in many laboratories, particularly in
the pharmaceutical industry. 2 Unfortunately, its more widespread application is
hampered by a general lack of mathematical and computer skills among researchers
and the cost of computer equipment and commercially available programs. NIH has
recently taken steps to overcome these problems. It financed the creation of the
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Biomedical Simulation Resource at Duke U niversity MedicalCenter, which makes its
facilities for building and examining mathematical models available nationally to
biomedical researchers. The resource offers technical advice and access to computers
and programs either at the facility or over a telephone data network.30
Computer models serve at leas t two general purposes in alternatives research.
F irst, they can substitute for animal tests, in some cases. The extent to which models
need to be backed up by animal tests depends on how well the models perform
during validation. The better the performance, the less the need for back-up tests.
In toxicity testing, models are likely to bring major reductions in animal use because
existing information from animal studies on thousands of compounds can be applied
toward predicting toxicity of closely related compounds that have not been tested.
The outlook is not quite as bright when models are applied in new areas of research,
since the results from the simplified models will have to be checked in the far more
complex living system.
Second, mathematical models can make animal research more humane by
identifying promising avenues of investigation and thereby preventing fruitless
animal research or by estimating the toxicities of a closely-related series of
compounds, so that only the least toxic compounds will be developed and tested
on animals.
These functions of mathematical models are illustrated in the following
examples and in the following chapter.
• Mathematical modeling has been used to determine the molecular
characteristics of cancer-causing chemicals. One hundred and fifty structurally related
chemicals were analyzed; each had been found previously to be either carcinogenic or
noncarcinogenic in animal studies.The model was an attempt to distinguish between
these two sets of chemicals based solely on molecular structure. 3 1 U sing the statistical
technique of pattern recognition known as discriminant analysis, researchers correctly
classified ninety-seven percent of the compounds. Such studies should encourage
further research in predicting toxicity from molecular structure. Success in these
endeavors will lead to a decrease in animal use for predicting toxicity.
• The potential value of mathematical modeling to cancer research has also
been illustrated byCharles Delisi and coworkers at the NationalCancer Institute.
According to a recent article, Dr. De
L isi's
computer program . . . analyzed the response of the immune system to
cancer. F rom information they gave the computer about tumor growth and
antibody production, it calculated that the immune system could not only
fight cancer growth but stimulate it as well. Researchers know that now,
says Delisi, "but if our model had been around ten years ago, it could
have predicted what it's taken scientists countless man-hours and animals
to figure out. This is the value of mathematical modeling - it comes up
with things that you might otherwise miss."32
• Mathematical modeling of malaria research illustrates the potential value of
modeling in guiding research efforts. This modeling was a retrospective analysis of
results from the testing of potential anti-malarial drugs. A large-scale testing
program had been conducted on mice at theWalter Reed Army Institute of
Research. Development of a structure/ activity relationship for a certain class of
chemicals synthesized early in the program showed retrospectively that further
research on this class was futile, yet many other chemicals in this class were
synthesized and tested in mice. This analysis suggests that prospective use of
mathematical modeling will prevent much futile animal experimentation. 33
• A computer program developed by thirty scientists at the Los Alamos
36
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NationalL aboratory is an ambitious attempt to duplicate the complex physiological
systems of the human body. 34The program is known as "HU MTRN," sho� �or
human transport. It is a data bank that gives simultane�>Us ac�ess t? ten million
.
pieces of information on what happens �hen any _ chemically �dentifia�le substance ts
taken into the human body. HU MTRN is dynamic to the pomt of bemg
programmed to eat, breathe, perspire, defecate, grow, _ develop sexually_. age, work,
and die. A scientist associated with the HU MTRN proiect has called this program
"the cutting edge of modeling technology."In one study, HU MTRN suggested_ that,
in most kinds of nuclear accidents, teenagers and young adults would be the highest
risk group in suffering long-term effects. The developers of HU MTRN refer to this
mathematical model as the "research rat of the future."
Use of Less Sentient Organisms

The seventy million vertebrate animals used in U .S. laboratories every year have
well-developed nervous systems and are, therefore, more likely to experience pain
and suffering than are invertebrate animals and microorg�sms. Invertebrates.
include animals without backbones, such as jellyfish, squid, earthworms, and msects.
Substitution of invertebrates for vertebrates, where feasible, would constitute a
refinement in virtually all cases. In
( some cases, decisions about relative levels of
sentience will need to be made carefully, as generalizations have exceptions.)
Similarly, substitution of vertebrate embryos for the more sentient adults would be a
_
refinement. Substitution of microorganisms such as bacteria and protozoa for
vertebrates would constitute complete replacement.*
The principle of using less sentient organisms even applies to pl�ts. P! ants, as
well as microorganisms and invertebrates, can be used to study baste biolog1Cal
processes. Two Nobel Prizes in medicine or physiology have been awarded for work
in plants. Hence, plants, as well as microorganisms, invertebrates, and vertebrate
embryos, can be considered "alternative organisms."
Alternative organisms are being used to develop scores ?f alternatives. 35 •36_ _
Several promising tests have already been developed, _ many m _ the field ?f toxicity
testing. Some will be discussed here; others will be discussed m the secuons on the
LD50 test and the Draize test.
• A simple test for detecting teratogens (chemicals that cause birth defects � has
been developed using hydras, tiny aquatic animals related to jellyfish. The test is
based on the observation that chemicals that cause birth defects in animals also tend
to disrupt normal development in hydras. This test is currently the most promising
alternative screen for teratogens. 37
• Plants may replace animals in tests to detect substances that c�use skin
damage in the presence of light. 38 Such substan_ces, termed phot?toxtm, ex�rt their
effects after being ingested or applied to the skm. Laboratory anunals, paruc�larly
hairless mice, are currently used routinely in phototoxicity tests. The alte!nauve test
is based on the observation that phototoxins inhibit the growth of yeast m the
presence of light. The test, developed by F. Daniels, yields results th_at are similar to
those from the mouse test when testing substances that are phototoxtc when applied
directly to the skin. Other alternative tests need to be dev�loped to detect s�b�tances
that are phototoxic after being ingested. Further research is needed on Damels s test
to corroborate and extend the encouraging results found to date.

*Research on microorganisms is sometimes characterized as in vitro because these organisms are so small
_
they can be cultured in laboratory containers. A differem classificauon ts adopted here m order to
_
emphasize the affinity between research on m1croorgarusms arid research on other orgarusms of limited
or no sentience.
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Physical and Chemical Techniques
Physical/chemical techniques exploit instruments and chemical procedures, not
animals, to analyze the physical and chemical properties of drugs, toxins, body
chemicals, and other substances. For instance, high performance liquid chromato
graphs and mass spectrophotometers are physicochemical instruments that accurately
isolate, identify, and measure the amount of a given substance in complex biological
mixtures. In high performance liquid chromatography, the test substance is forced
through a column of silica and different chemicals pass through at different speeds.
This characteristic is used to analyze precisely the components of the substance.
Physicochemical techniques are replacements when used instead of animals to
assay substances. They are reductions when they perform their analyses better than
cruder methods and thereby require fewer animals per experiment. Numerous
technical improvements can be considered as physicochemical reduction alternatives.
For example, a device is now available that divides a one-microliter sample (which
itself is tiny) into one thousand subsamples, each of which can be analyzed
biochemically. 42 It is easy to see how the use of such an instrument could reduce the
number of animals needed as sources of tissue samples.

VI. The Ames test: each plate contains a culture medium
incapable of supporting the tester bacteria unless the latter
undergoes mutation. In A, bacterial colonies, seen as white
dots, descended from bacteria that mutated spontaneously; in
B-D, mutation was increased by adding chemical mutagens.

• Physicochemical techniques have replaced the use of animals in assays for
vitamins A , D, andE and for "biologicals" such as the hormone oxytocin. In the case
of vitamin D3 , the new technique involves high performance liquid chromatography
and provides a simpler, quicker, and cheaper alternative to the animal bioassay. The
latter procedure involved inducing a vitamin D3 deficiency (rickets) in rats and
administering D 3 -rich substances such as cod liver oil over several weeks - a laborious
and time-consuming method. 4 3
• Physicochemical techniques have replaced the use of rabbits in human
pregnancy tests. Nowadays, one can obtain pregnancy diagnostic kits from the corner
drug store. These kits contain simple materials to screen a potential mother's blood
or urine for a chemical associated with pregnancy.

In addition to bacteria, the A mes test also makes use of in vitro culture of liver
enzym �s- Rats are the recommended source of livers, although human cadavers have
potential. 39Whatever the source, the culture contains the microsomal structures
mentioned in the test's alternate title, the Salmonella/Microsome test. Potential
�utagens_ are i_ncu_bat�� wi�h this culture in or ?er to s�ulate a process known as
metabolic activation, which normally occurs m the ltver (and to a lesser extent in
other organs) of intact animals. Unless activated, mutagens might not exert their
effects and would thereby escape detection.
. The Ames test has been improved continually since its introduction and now
gi�es res �lts com.l?arable t<;> those_ of �nimal bioassays. It has the added advantage of
bemg quick and mexpensive. It is widely used as an initial screen often in
combination with other short-term tests, and therefore has reduc�d the demand for
laboratory animals in carcinogenicity testing. A considerable number of mutagens
fu�t detected by the Ames test have been shown subsequently to be carcinogenic in
animal tests.40
Abo_ut ni �ety p�rcent of �nown carci�ogens can now be detected by short-term
mutagemc testmg usmg battenes of tests. These tests are inexpensive and can be
conducted in one to five days.

Other Techniques
Other techniques or systems may be used to replace, reduce, or refine the use of
animals in research. These include mechanical models, veterinary patients, and
computer-aided drug design.
Mechanical Models: animals are sometimes used to study effects of accidents
such as vehicle crashes and specific injuries such as burns. Mechanical models are
being developed that might replace animals in these studies. For example, an
artificial neck developed by General Motors is being used in car-crash simulation
tests, and a human simulator known as Thermoman is being used to test potential
burn risks with different garments. 44
Veterz·nary Patients: just as clinical studies of humans can reduce the demand for
laboratory animals, so, too, can clinical studies of animals. A nimals are susceptible to
many of the same illnesses and injuries that plague humans. A nimals that are
already sick could be studied while undergoing treatment, and the resulting
knowledge could benefit human health. O
( f course, the primary concern in these
studies should be the animals.)Clinical studies of animals could reduce the
number of laboratory animals that are deliberately sickened or injured in
experimental studies.
Prof.Calvin Schwabe, a respected research veterinarian, argues that both clinical
and epidemiological studies of animals are being virtually overlooked as potential
resources for understanding human diseases. The relevance of spontaneously
occurring diseases in animals to medical research on humans is unappreciated. A
consequence of this, according to Schwabe, is that most of the research in compara
tive medicine that is being conducted by physicians is focused upon the potentially
least rewarding approach to animal diseases, namely, studying artificially induced
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•. The Ames test uses _bacteria to detect mutagens (chemicals that induce genetic
mut �tions). Because mutations are often associated with cancer production, the A mes
test 1s used as a screen for carcinogenicity. This well-researched test is now a classic
example of an alternative. It uses a specially prepared strain of the bacterium
Salmonella typhimun:um. The_ culture medium is designed so that only bacteria that
have undergone certam mutations are capable of growing.
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rather than spontaneous diseases.Veterinarian Michael Fox, in recounting Schwabe's
view, calls for greater collaboration between veterinary and medical researchers.45
Computer-Aided Drug Design: discovering new drugs is largely a
trial-and-error process, costly in terms of time, money, and animals. It takes eight
years, on average, to screen a new substance from the seven thousand to eight
thousand novel compounds created each year and to bring it into medical practice.46
Fortunately, methods are being developed to replace this shotgun approach with the
more directed approach of computer-aided drug design. Three-dimensional
computer graphics and the theoretical field of quantum pharmacology are being used
in efforts to design drugs with particular specifications. These efforts are based on
the lock-and-key mechanism of drug action; that is, drugs must be the right shape
and composition in order to "dock" with their targets and trigger their effects. Color
graphics help visualize this process.
A lthough computer-aided drug design is in its infancy and is highly theoretical,
there are indications that progress is being made. Several "drug designers" have been
included on new drug patents for aid in discovering drugs. 47 A new drug being
tested clinically for effectiveness against high blood pressure was designed with
computer methods.48 Perhaps it is not surprising, then, that several pharmaceutical
companies now employ such "drug designers."
Much of the work in computer-aided drug design is apparently being conducted
in Britain, where it has received some financial support from the Lord Dowding
Fund. However, researchers at the University of Pittsburgh are collaborating with
British researchers in attempts to use computer-aided methods to design a drug to
treat sickle-cell anemia.49New efforts such as these hold great promise for reducing
animal use by revolutionizing the process of drug discovery.
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Case Studies :
The LD50 Test
And the Draize Test
MUCHOFTHE public outcry against the use of animals in toxicity tests has
centered on the 1D50 test and the Draize test.It is not surprising, therefore, that
much of the research into developing alternatives in toxicity testing has been directed
at these two tests. Substantial progress in this research has been made during the last
five years.
The 1D50 Test
The 1D50 test was developed in 1927 to standardize the potency of potentially
poisonous substances destined for human use, such as diphtheria toxin, digitalis
· extract, and insulin. A lthough not originally designed to do so, the test gradually
became incorporated into routine toxicity programs for testing new chemicals.
Government regulations in the U.S. and abroad specified the 1D50 test for
evaluating new drugs, food additives, cosmetics, household products, industrial
chemicals, and pesticides.Each year in the U.S., four to five million rats, mice,
guinea pigs, and, less frequently, rabbits, dogs, and primates, are subjected to
this test. 1
In the 1D50 test, test substances are force-fed, inhaled, injected, or applied to
the skin of animals.Of these variants - the oral, inhalation, injectable, and dermal
1D50 tests, respectively - the oral 1D50 is the most common.It produces signs of
poisoning including bleeding from the eyes, nose, or mouth; labored breathing;
convulsions; tremors; paralysis; and coma.
The classical 1D50 test uses large numbers of animals to derive a numerical
index of toxicity (the 1D50 value). This approach has two major scientific problems.
First, the test is of limited value in protecting human health. This limitation stems
primarily from an overemphasis on the 1D50 value. Sometimes, little or no
.
additional information (such as poison symptoms, body organs affected, and specific
cause of death) is gathered. This important information could be derived from
relatively few animals. A ccording to D.V.W. Parke, the "counting of cadavers"
should be replaced by full clinical and postmortem studies using fewer animals. 2
Even when the 1D50 value is supplemented with clinical and pathological
information, public health officials can still be at a loss to infer the maximum safe
dose of the test substance in humans. The 1D50 provides the median lethal dose,
not the safe dose. Moreover, the lethal dose, as ill-suited a measure as it is, still has
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This variation is not surprising given that the 1D50 value depends on a host of
biological and extraneous factors. A ccording to Zbinden, these factors include
... species, strain, sex, age, and weight of the animals, abundance and
composition of diet, volume and speed of administration of the test
substance, vehicle, solubility, and particle size, concentration, ambient
temperature, housing conditions, and even the seasons of the year. This
means that the 1D50, even if it is determined with high precision with a
large number of animals, is not a biological constant. 7
The precision of the classical 1D50 test is also called into question by regulatory
practice. Most 1D50 testing is conducted according to regulatory guidelines.
Ironically, the same guidelines that call for precision usually specify that 1D50 values
are to be lumped in limited numbers of broad categories for labeling purposes.
Thus, all of that precision, gained at such cost in animal suffering, is lost
in categorization!
These scientific problems with the classical 1D50 test provide a compelling
rationale for developing and using alternatives.Equally compelling is the ethical
problem - the suffering and death of millions of animals in a test of such dubious
value. Several alternatives to the classical 1D50 test are available. They could reduce
the demand for animals, as well as save time and money, without compromising
human health.
Some of these alternatives are modifications that would require fewer animals:

VII. Rat being force-fed a pesticide in an W50 test

• One test uses six to ten animals to determine the Approximate Lethal Dose
(ALD). This test was discussed earlier as an illustration of reduction alternatives in
toxicity testing.

to be extrapolated from, say, rats, to humans. This extrapolation is nearly
meaningless. A ccording to toxicologist G . Zbinden of the University of Zurich:

• The Limit test involves giving a small group of animals ( ten to twenty) a
single dose of a test substance. If no ill effects are seen, no further testing at higher
doses is required. The accepted maximum dose for the test depends on the nature of
the substance being tested. 8The Limit test is especially useful for relatively harmless
substances, which would necessitate unrealistically large doses in the classical test.

The marked species differences in acute toxicity are well recognized,
making it impossible to predict the human lethal dose from the results of
animal experiments.With such enormous variations between species, it is
clear that the knowledge of the 1D5 0 in a mouse or a rat does not provide
much support for the prognosis in a human case of acute poisoning. 3

• In the Up-and-Down test, each animal receives a single dose, but that dose
changes as the six or so animals are sequentially tested. The dose is lowered after
signs of severe toxicity develop or is raised after an animal survives on� week without
such signs. The resulting information is evaluated in a commonly available computer
program. The test yields a reasonable estimate of the 1050. 9

A second problem with the classical 1D50 test is its unnecessary precision. Large
numbers of animals are used to derive a precise estimate of 1D50, yet that estimate
can be applied to humans in a rough manner only. A ccording to Rowan, "If the
1D50 figure of a compound is 100 milligrams per kilogram of body weight for a
mouse, it could easily be anywhere between 10 and 10,000 milligrams per kilogram
body weight for a human being. "4
The illusary precision of 1D50 values applies to animals as well as humans.
Calculated 1D50 values for the same chemical can vary substantially among
laboratories (inter-laboratory variation) and among laboratory animal species
(inter-species variation). For example, a study of inter-laboratory variation was
conducted under the auspices of theEuropeanEconomicCommunity. 5 Sixty-five
laboratories were instructed to determine the rat oral 1D50 for each of five
chemicals. LD50s were determined separately for males and females, as is customary.
The calculated values varied from four- to twelve-fold in males and three- to
seven-fold in females. Similar inter-laboratory variation was found in another
comparative study. 6

• Other techniques also use fewer animals than the classical 1D50 and yet yield
1D50 figures of satisfactory precision. These include the "moving averages" technique
and a graphical method suggested by Molinengo. 10
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These modifications of the 1D50 test use substantially fewer animals than the
classical test and, therefore, qualify as reduction alternatives. The Limit test, by its
very nature, is also a refinement alternative in that it reduces exposure of animals to
pain-inducing doses. All of these modifications could qualify as refinei:nents if
animals that were acutely suffering and dying were instead painlessly killed and
counted among those that died or exhibited severe toxic reactions. 11 This refinement
was recently recommended by the British Toxicological Society.
Many toxicologists who conduct acute toxicity tests such as the 1D50 make at
least some use of these alternatives, especially the Limit test. 12The U.S. cosmetics
industry substituted theL imit test for the classical 1D50 test and there� y �educed
animal use by seventy-five to ninety percent, according to a trade association
survey. 13 A nd AlliedCorporation has abandoned the classical 1D50 test in favor of
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the "Up-and-Down" test. A nimal use was cut in half. This innovation and others
are yielding more information, cutting costs, and reducing the stress of those animals
that are used.14
These examples may represent just the tip of the iceberg; the consensus among
participants at the second symposium of theCenter for Alternatives to A nimal
Testing was that reduction alternatives could completely replace the classical
1D50 test. 1 )
Alternatives to the classical 1D50 are not limited to modifications of the test
itself. They also include mathematical models, in vitro techniques, and
alternative species.
Mathematical models are being developed to predict 1D50 values without using
animals. The most promising of these models is that of KurtEnslein and his
colleagues at Health Designs, Inc. The model predicts the oral 1D50 values for rats,
based solely on a chemical's structure and properties. The model, created through an
analysis of nearly two thousand chemicals that had already been tested in rats, was
evaluated by generating predictions on the 1D50 values of another 900 compounds
that had already been tested. The predicted values were similar to the actual values
obtained in animals.
The researchers concluded that their model could be used competitively with the
rat 1D50 test. It has many advantages: elimination of unnecessary animal testing,
lower cost, faster response, and greater repeatability. K.Enslein suggested a number
of applications: (1) estimating the doses to be used in animal-based 1D50 tests (this
application could spare animals from being tested at doses that are too small or large
to be meaningful); {2) selecting least toxic compounds by obtaining estimated LD50s
on similar compounds before they are synthesized, then ranking these estimates to
decide which compounds to investigate further (this application could spare animals
from being tested with highly toxic substances); and (3) supplying data for any acute
toxicity studies as needed. 16
The major limitation of the model is that it cannot, as yet, generate estimated
1D50 values for all compounds, owing to technical problems.Enslein and his
collaborators have discussed this and other limitations of their model, adequately
addressed their critics, and discussed future plans to improve the model and render it
more understandable to toxicologists. 17 This latter development will hasten the
model's evaluation and possible application.
The model is likely to be used initially as a preliminary screen, backed up by
animal testing. During this period, the model could be improved. If it then inspires
confidence, it may totally replace 1D50 testing in animals.
Cell-culture alternatives to the 1D50 test are being developed by a research
program coordinated by FRAME. 18 The program involves four laboratories in the
United Kingdom and is financially supported by numerous commercial and
nonprofit organizations. The aim of the program is to develop a tier approach to
acute toxicity testing:
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replace in vivo testing, their judicious use clearly has great potential. 19
A nother potential alternative to the 1D50 test involves the use of less sentient
organisms. U sing a series of alcohol compounds as test chemicals, researchers recently
obtained an excellent correlation between 1D50 values in mice and inhibition of
movement in tubifex worms.20These findings need to be extended through the
testing of other compounds that have already been tested on animals but not yet
tested on worms.
G iven the inadequacies of, and the alternatives to, the classical 1050 test, it is
not surprising that support for the test is eroding in all quarters. Even toxicologists
have criticized it. Dr. S.B. de
C. Baker stated that acute studies such as the classical
1D50 "are of little use and are expensive in animals. The main information they give
is an indication of the. . . dose required to commit suicide. "21 Zbinden called the
1D50 "a ritual mass execution of animals."22 Dr. D.P. Rall, director of the United
States-based National Toxicology Program, called the 1D50 "an anachronism. I do
not think the 1D50 test provides much useful information about the health hazards
to humans from chemicals . . . ."23 The Pharmaceutical Manufacturers A ssociation,
which represents 149 research-based pharmaceutical companies in the United States,
stated that "A dvances in toxicity testing now make it possible to conduct most
drug-safety evaluation without theClassical 1D50 test."24Even theNational Society
for Medical Research, which promotes and defends the use of animals in biomedical
research, has backed away from the LD50. Its new position is that "The routine use
of the quantitative 1D50 test is not now scientifically justified . . . : m
Despite these statements, the classical 1D50 test has not been abandoned. A
1983 survey of toxicologists who conducted acute toxicity tests revealed that eighty
percent used the classical 1D50 test. 26
Perhaps the only scientifically legitimate use for the classical 1D50 test is in rare
cases in which drugs have a narrow margin of safety, so that toxic levels have to be
precisely determined. 27 So why does the widespread use of the classical 1D50 test
persist? The main reason cited by the manufacturing and testing companies that
participated in the 1983 survey was to satisfy regulatory requirem<;nts. 28 Of cours<; , by
satisfying regulations, these companies may feel better armed agamst damage claims
brought by consumers. Perhaps these companies have difficulties in breaking an old
habit. For their part, regulatory agencies also seem worried about consumer backlash
and seem to be plagued by bureaucratic inertia.
A major regulatory obstacle for products marketed internationally is the
Organization forEconomicCooperation and Develop�ent (�ECO). O
_ ECD
.
guidelines require that the 1D50 test be conducted pnor to mternauonal marketing
of products.Companies whose products have any chance of being marketed overseas
may automatically conduct 1D50 tests, regardless of whether or not the products are
eventually marketed internationally.

Work on this program is in progress. Preliminary results on Level 1 are
encouraging. The fundamental property being examined is protein synthesis by
human embryonic cells. In this procedure, toxic chemicals administered to these cells
inhibit protein synthesis.The test yields an 1D50 value, the dose causing fifty
percent inhibition of protein accumulation. 1D50 values are well correlated with in
vivo 1D50 values. Although cell-culture tests such as this one may never completely

The Draize Eye-Irritancy Test
The Draize test is a method of assessing the eye- irritancy potential of various
substances including cosmetics, toiletries, household products, ophthalmic drugs,
pesticides, and industrial chemicals. The test was developed following passage of the
Federal Food, Drug, andCosmetic Act of 1938, which mandated (among other
things) that cosmetics be free of substances poisonous or deleterious to the user.
Today, the test is a routine component of toxicology p�ograms '.1-°d regula�ory
evaluations worldwide. However, prospects for developmg and 1mplemenung
alternatives appear promising.
The Draize test is performed almost exclusively on albino rabbits. It� �r?cedures
have been modified several times since its adoption. A fixed dose (0.1 milhhters or
O. 1 grams) is placed inside the lower lid of one eye of six to eighteen rabbits. 29The
lower and upper lids are then briefly held together to d�stribute the te�t substance on
the eye surface. The other eye is left unused for comparison. The rabbits are
restrained during the procedure and later immobilized in stocks to prevent them
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Level 1: In vitro testing for gross toxic effects on fundamental properties of
cultural cells,
Level 2: In vitro testing for specific toxic effects on particular target organ
cells, and
Level 3: In vivo testing, if necessary.
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Perhaps the most significant problem with the Draize test is its questionable
applicability to humans. There have been many cases of discrepancies between the

test results and human experience. 32 Rabbit eyes are, in most cases, more sensitive
than human eyes, 33 partly because rabbits produce smaller quantities of tears than do
humans. (Rabbits possess a nictitating membrane or "third eyelid," which may
partially compensate for the reduced tear flow.)
Results of Draize tests are expressed in a way that makes the relevance of those
results to human experience highly suspect. Test substances can cause different forms
of eye damage to different degrees, and these are graded to yield numerical scores.
These scores are weighted to reflect the purported relative importance of damage to
different eye parts, then added together to yield a composite score. This score is
interpreted as indicating the degree of irritant potential of the test compound.
Ballantyne and Swanston have criticized this numerical Draize score as uninformative
and meaningless.34
Several potential alternatives to the Draize test are either being developed or are
already available. Some are modifications of the Draize test that would reduce either
the number of animals used or the pain and suffering of the ones used. Others are
new tests that are potential replacement or reduction alternatives. Eventually, a
suitable battery of tests to replace the Draize test completely is likely.

VIII. Rabbits immobilized in stocks as part ofa Draize test

from rubbing or scratching their eyes.
The rabbits' eyes are examined at specific times after exposure to the test
substance (e.g., at 1, 24, 48, 72, and 168 hours). Damage to different parts of the
eye is rated on separate scales. The maximum scores for damage to the cornea,
conjunctiva, and iris are eighty, twenty, and ten points, respectively. These scores are
added to yield an overall score for eye injury.
Eye irritation in the Draize test usually consists of reddening and swelling of the
conjunctiva and iris and clouding of the cornea. Eye damage can be readily
anticipated when substances such as hydrochloric acid, formaldehyde, alcohol,
industrial solvents, drain cleaner, laundry soap, dish washing compounds, and
shampoos are tested. Animals that survive the test with minor injuries are sometimes
used for other laboratory studies, such as skin-irritancy testing, before they
are killed.
The Draize test undoubtedly has been of some help in deciding whether or not
substances are safe for human use. However, as the test for preventing ocular injury
to humans, it leaves much to be desired. A major problem is that the test is
unreliable. In cases in which particular substances were tested several times (either in
the same laboratory or in different ones), it has not been uncommon for the same
substance to be classified as an irritant in some instances and as a nonirritant
in others. 30•3 1
Such differing results may have been caused by variation in the scoring of
similar degrees of eye damage or the haphazard distribution of the test substance on
the eyeball.
The Draize test is also crude. It yields a score that is used to determine whether
or not a test substance is an irritant - virtually a pass-fail test with an arbitrary
cut-off point. For many substances, the imponant question for protecting human
health is not whether a substance is an irritant, but how much of one it is.

The volume of test substance routinely instilled in the eye is 0.1 milliliters (ml).
Although this dose seems tiny, it is huge in relation to the fluid-holding capacity of
the eye. Swanston has called this dose excessive and irrational. 3 �
Studies have shown that a smaller dose (0.01 ml) would give better results 36 and
cause less eye damage. 37One such study was prompted by the suggestion from the
National Academy of Sciences that a smaller dose could appreciably reduce the eye
damage of test animals to a range more consistent with human experience. 38 Lower
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IX. A rabbit's eye damaged in a Draize test

Let us first consider the modifications of the Draize test that have
been proposed:
(1) Use of anesthetics or antihistamines.
We know that the use of certain anesthetics would not appreciably affect results
of the Draize test.

(2) Use ofsmaller doses.
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doses are not only a humane refinement, but are also likely to yield results of greater
relevance to protecting human health.
Using weaker dilutions of a test substance has the same effect as using smaller
doses. N.J. Van Abbe recommends using dilutions when a substance is likely to
cause severe reactions at the routine dose. 39 Such dilutions have the scientific
advantage of enabling finer discriminations to be made from the results. A ccording
to Van A bbe, the discrimination can also be enhanced by simultaneously comparing
the results with those from a reference standard.
(3) Use of noninvasive techniques.
One technique used to document eye damage in the Draize test involves killing
the test animals and surgically excising eye tissue. However, several noninvasive and
nonlethal refinements of this procedure are available. These include measuring
corneal thickness using an optical device, measuring intraocular pressure using a
hand-held instrument, and measuring the corneal reflex using a taut string and a
simple device. 40 If these procedures were adopted, all animals would survive the test.
(4) Use offewer animals.
The Draize test currently calls for six to eighteen rabbits. In a study
investigating the effect of the number of test animals on the test's precision,
increasing numbers from one up to six yielded marked improvements in precision. 4 1
However, increasing numbers to nine or twelve yielded "little further benefit when
set against the increase in animal numbers." Hence, six animals should suffice, in
most cases.
A more far-reaching reduction alternative was suggested by Koeter and van
Vliet, who recommended that a preliminary Draize test be conducted with only one
animal. 42 If severe irritation resulted, testing should stop. If irritation were less than
severe, a few more animals could be tested, as necessary.
One can readily imagine other reduction alternatives to the Draize test. Dr. G.
Flamm of the Food and Drug A dministration recently recommended that any
substance found to be an irritant at a low dosage should not be tested on more
animals at higher doses. 43
It is unlikely that the Draize test could be refined to the point where all pain
and stress were excluded.Even if anesthesia and weak dilutions of test chemicals
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were used, the rabbits would still be living in stockades, which is undoubtedly
stressful. Indeed, "rabbits not infrequently break their backs as a result of struggling
to escape" from the Draize stocks. 44 This brings us to consider alternatives that would
replace, or at least reduce the demand for, the Draize test.
The most widely known alternative replaces rabbits with chicken eggs. A portion
of the eggshell and adhering membranes is removed from a fertilized egg when the
embryo has developed for two weeks. This procedure exposes the "chorioallantoic
which surrounds the embryo. A small amount of a potential
(
membrane" CAM),
irritant is applied to a section of theCAM. A positive response can include
cloudiness, inflammation, and proliteration of blood vessels, but since theCAM has
no demonstrable nerve supply, the embryo feels no pain.
Initial results from the CAM test show a good correlation with results from the
Draize test. 4 )This promising alternative is now in the "validation stage" and is being
funded by various animal-welfare organizations in the United States.
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XI. The chorioallantoic membrane (CAM) test: test chemicals are placed on
a portion of an insensitive membrane of a fertilized chicken egg to test for
im"tancy

X. A cell culture, enlarged 200 times
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Many potential alternatives to the Draize test involve in vitro systems. One is an
organ culture of isolated eyes. Eyes can be obtained from human or animal cadavers,
especially from sources such as slaughterhouses. An example of this organ-culture
method is the Enucleated Rabbit Eye test, which has yielded promising results. The
strengths and limitations of this type of test have been discussed by
D.W. Swanston46 and M. York. 47
A nother organ-culture system involves isolated corneas, as distinct from entire
eyes. 48Rabbit or bovine corneas are incubated with suspected irritants. Irritancy is
inferred from changes in corneal thickness, ratio of wet weight to dry weight,
microscopic anatomy, and corneal enzymes.
Other potential in vitro alternatives to the Draize test involve cell-culture
systems. The cells for these tests are derived from a variety of sources, including the
human cornea, mouth lining, and blood (leucocytes); rabbit cornea; rat abdominal
cavity; and mouse embryo and connective tissue. In these tests, chemical irritancy is
inferred from a variety of end points, including cell death, cellular release of
substances associated with irritation, cell membrane damage, changes in cell
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movement or metabolism, and the rate of wound healing.Examples of these
cell-culture alternatives include the Rat Mast Cell assay, the Fluorescin Diacetate test
the Haemolytic Activity test, and a variety of as-yet-unnamed tests. 49 , ,ll
The Rat MastCell assay is already in limited use by the Johnson and Johnson
Company. Mast cells are derived from connective tissue and are involved in
inflammatory responses. The assay monitors the cells' release of the chemical
serotonin. J. _Mc �ormack reported that "the procedure has a high degree of
correlation with �n �111? test results. In addition, it is easy to perform, accurate, and
repeata?le, and it li m�ts the scope of in vivo testing. ") 2 The assay is used as a screen
_
to elimmate severe irntants from in vivo testing. However, only a single class of
comp?unds w� ev�_uated, so it remains to be seen whether the Rat MastCell assay
has wider apphcabday as a substitute for the Draize test.
Cell-cultu!e tes�s funded by _ Revlon are producing encouraging results. Two
such t�sts momtor eit�er anato�mcal changes in cells or_ inh�bition of cellular uptake
of an important �hem1eal constituent. Rockefeller Umversity researchers obtained
excellent correlations between the results of the two tests and the Draize test.
Perhaps the most promising c:ll-culture alternative to the Draize test is being
developed at theEye Research Institute (Boston) and Harvard Medical School. The
test _ is based _ on t�� observation that when the surface of a rabbit or human eye
:ece1v �s � mmor IIlJury, healthy cells migrate over the wound and proliferate to heal
lt. lrntatm� c_hemicals slow this healing process. To investigate this inhibitory effect,
researchers mJure two types of rabbit corneal cells in vitro, normal cells and those
treated with an_ irrit �nt. The rate of wound healing is measured by staining the
wounds and usmg time-lapse photography. The degree to which a substance slows
the response is an indicator of the substance's toxicity.
J?r. A . Ne_ufeld, one of the developers of this test, recently commented, "Not
only 1s the Draize t��t a poor way to treat animals, but the in vitro method appears
to be far more sensitive and far more relevant. ")4 Preliminary results using human
cells suggest that the methods developed for rabbit cells can be successfully applied
to human cells.
!'1- _ prom_isin� tissue-c_ulture �ternative to _the Draize test utilizes excised strips of
ra�bit mtestme. Some sixteen pieces can be isolated from a single animal.When
sui�ably cultured, these str�ps will contract sp?ntaneously for hours unless chemically
poisoned. The test determmes the concentration of test chemicals necessary to block
�fty perce�t of the contractions.This test is based on the premise that some damage
m the Draize test occurs when chemicals penetrate cells on the eye's surface and
damage �ells �t low�r levels. The surface cells can be viewed as a penetration barrier
to chemicals; mtestmal cells mimic this barrier effect. The results of this test have
comp �ed very _ favorably_ with in vivo data. One rabbit could provide enough
matenal for thuty expenments, and the technique could be used for two-thirds of
the Draize tests currently performed. )G
The outlook fo � major changes in routine eye-irritancy testing is bright.
Researc� on alternatives to the current Draize test is active and varied, thanks largely
to public outcry over the treatment of animals in this test. Refinements and
reduction alt�rnatives to the Draize can be implemented immediately.
Imp_lementat1on ?f replacement alternatives probably will be gradual, as alternatives
are mcorporated into a suitable battery of tests.
While the Draize t_est is _ st�ll i -?- use, alternatives can be used in a supplementary
manner to screen out highly umat1ng substances and to determine doses that will
yiel ? mi!d rea�tions in the Draize test. Before considering any form of eye-irritancy
testing, mvestigators should ask whether a particular substance needs to be tested at
all.Certain substances need not be tested because they are almost certain to cause
eye irritation. These include substances that are highly acidic or alkaline and those
that are already known to be severe skin irritants.) 7
A s with the LD50 test, efforts to make eye-irritancy testing more humane
should be directed to government regulators as well as to product manufacturers and
)0
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laboratori :s. Such efforts should focus on eliminating variables in
their testing
_
m unnecessary replication and on circumventing bureaucratic
result
that
at1ons
egul
_
:
_
mema to accepting proven alternatives.
Recall that one reason for the persistence of the classical LD50 test is the claim
that it is necessary to protect manufacturers against untoward legal action. A similar
claim has _ been made with regard to the Draize test. However, in one legal action
tak�n against a _manufacturer of a sham]?oo that damaged someone's eye, rabbit-eye
testmg �as a mmor part of the case. This case (United States v. An Article of
Cosmettc . . . Beacon Castile Shampoo. . . ) merits discussion here because both
supporters and opponents of the Draize test claim that it supports their arguments.
. The case was a civil suit brought by the Food and Drug A dministration (FDA)
against the manufacturer in the wake of an eye injury sustained by a young girl. The
girl dropped a container of shampoo, and the contents splashed up in her eye. To
support its case that the shampoo was dangerous and therefore should not have
been marketed, FDA commissioned a Draize test in rabbits and a study of
human volunteers.
Despite the fact that the shampoo injured the rabbits' eyes, the court ruled
against FDA and in favor of the manufacturer. In a discussion of this decision, the
G eneral A c counting Office emphasized that FDA failed to show that "the results of
test on rabbit eyes can be extrapolated to humans. . . . ") 8 This statement is significant
because it apparently undermined the manufacturer's defense-against-liability
argument for conducting the Draize test.
Unfortunately, the issue of extrapolating from rabbits to humans was not the
keyston� of the judge's decision. )9 The primary reason for the ruling was that the
FDA faded to show that the full concentrate of shampoo might get into the user's
eye under the usual conditions of use and that the user would not automatically
flush out the eye. 60
Nevertheless, the judge did state that the "rabbit studies, standing alone, do
not warrant condemnation of this product." The judge refused to accept
extrapolations from rabbit-test results to human response without confirmatory data
�rom research on human volunteers. In this case, FDA submitted conflicting and
mcomplete results of human studies. A lthough a complicated and multi-faceted
case, the BeaconCastile decision does provide evidence that a court did not find
rabbit-eye testing particularly helpful in determining the extent of human hazard.
G iven the judge's comments, it is rather surprising that a spokesperson forThe
a manufacturer's trade group,
(
Cosmetic, Toiletry, and Fragrance Association CTFA),
asserted that the case "provides support for use of the Draize test as a reliable
method of substantiating that a product is safe for eye-area use."61 According to the
CTFA, the judge reasoned that rabbit eyes are more sensitive than human eyes in
that t�e former have less capacity to tear and flush away an irritant; therefore, any
chemical that does not injure rabbits' eyes is not likely to injure human eyes.
TheC l!A supersensitivity-as-an-asset argument is unsupported not only by the
Bea.conCastile case, but also by toxicological principles. A lthough supersensitive
species �� well-suited for c�mfid��tly identifying harmless substances, the strength
of a tox1C1ty test should be its ability to detect harmful substances. If a test is
supersensitive, it will overclassify substances as harmful. This would be the
toxicological equivalent of "crying wolf." The test's results could easily be explained
away, much as studies identifying cancer-causing substances in laboratory animals
sometimes are dismissed because the huge doses utilized may cause cancer by
overwhelming the body's metabolism. Use of a less sensitive species or system could
be more valuable in protecting human health, as well as more humane.
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Alternatives in Education
Introduction
Education accounts for less than ten percent of the current level of laboratory
animal use in the United States, 1 but this figure belies the importance of
applying the alternatives approach to education. Scientists of tomorrow will be more
likely to adopt the approach if they are exposed to it as students. Recently educated,
young scientists are likely to play an important role in the development and
implementation of alternatives.
Even students who have no desire to become scientists may nonetheless benefit
from exposure to the alternatives approach. These students will come away with a
better appreciation of animals and a more positive view of scientists' activities.
According to biology teacher G . Russell, the power of science without the
control of compassion and admiration for life is too immense to be applied merely
for the satisfaction of scientific curiosity. If biology were taught in a manner that
developed a sense of wonder and of reverence for life, and if students felt inwardly
enriched from their study of life, these students would formulate as a life-long goal
the steadfast determination to protect and preserve all life and would bring healing
to a world desperately in need of it. 2
These philosophical changes might even motivate some students to consider
careers in science.
Recognizing the importance of reaching young students, the American F und for
Alternatives to Animals in Research supports annual training sessions in in vitro
toxicology for students planning a biomedical career.
This summary of alternatives in education applies primarily to the college and
graduate levels, where the challenge for the alternatives approach is the greatest.
Discussions of alternatives that focus on the pre-college level can be found in several
compilations of humane biology projects. 3 The challenge for alternatives at the
post-secondary level is not in devising projects that convey the general principles of
biology, but in devising ones that convey specific information or confer specific skills.
Examples include learning surgery without practicing on animals, learning
comparative anatomy without killing large numbers of animals, or learning the
effects of common drugs without giving those drugs to animals.
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Alternatives

There is a wide variety of alternatives to educational uses of animals.

(1) Surgical Apprenticeships
In the United States, medical students practice surgical techniques on animals.
This custom accounts for half of all animals used in medical education. 4 A n
alternative is the British system: medical students in Britain gain their initial
experience in surgery by observing demonstrations on cadavers . Then comes a clinical
apprenticeship: students observe experienced surgeons operating on sick humans,
gradually begin to take part along with the surgeons, and finally carry out operations
under their supervision.
The using of animals solely to gain surgical dexterity is prohibited in Britain by
the Cruelty to A nimals Act of 1876. A ccording to the Royal College of Surgeons of
England, the prohibition "has not proved an obstacle to the effective training of
young surgeons in the United Kingdom." 5 This view is supported by a recent study
of British and American surgeons, which indicated that practice surgery on animals
made no difference to long-term competency. 6
A simifar prohibition applies to the use of animals in training veterinary
students in Britain. These students train with experienced veterinary surgeons and
use animals that need the operations for therapy. A ccording to the BritishVeterinary
Association, "The idea of making healthy animals sick for purposes of training is
totally repugnant to the [veterinary] profession in this country. "7
Unfortunately, this is not the case in U.S. veterinary schools, where healthy
animals - primarily dogs and sheep - are subjected to practice surgery. Such
procedures account for a significant percentage of the animals used in
veterinary education.8
(2) Placentas for Microsurgery
A pprenticeships work well for practicing most types of surgery but are ill-suited
for the new field of microsurgery. Used primarily to reconnect severed fingers or
hands or to reconstruct badly damaged tissue, microsurgery involves, among other
things, reconnecting tiny blood vessels. It is not the sort of operation a trainee can
readily learn at the shoulder of an accomplished microsurgeon.
For this reason, Britain is considering lifting its ban of practice surgery on
animals for microsurgery. However, a promising alternative using human placentas,
funded by the Lord Dowding Fund for Humane Research, is being developed by
Dr. PaulTownsend, a plastic surgeon at the Frechay Hospital inEngland. The
surface of the placenta has blood vessels of various sizes that can provide
opportunities to practice microsurgery. A pump simulates blood flow through the
vessels. Unfortunately, the pumped blood cannot clot, and clotting is a primary
consideration in clinical microsurgery. Dr. Townsend thinks that this limitation can
be overcome and that placentas can be a replacement for animals in microsurgery
training. 9
The British newspaper The Guardian has suggested that the British government
should encourage development of the placenta alternative rather than rel ax controls
on animal use in practice surgery. 10
(3) Comp uter-Assisted Mannequins
Carefully designed mannequins can simulate the appearance and selected
responses of humans or animals and, therefore, can play an important role in
education.Widely cited examples include Sim, the mannequin discussed earlier, and
"Resusci-Dog," a canine mannequin that teaches cardiopulmonary resuscitation to
students at the New York State College ofVeterinary Medicine. Resusci-Dog, whose
development was supported by the G eraldine R. Dodge Foundation, is one
component of a computerized cardiopulmonary emergency simulator that confronts
students with various "emergencies." It also evaluates the students' diagnoses and
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· XII. Resusci-Dog is a canine mannequin used in teaching
cardiopulmonary resuscitation at New York State College of
Veterinary Medicine.

treatments and causes "patients" to respond realistically. The latest version costs
$1,200 11 and has replaced 100 dogs per year in veterinary classes at the New
York school. 12
.
.
.
ers, �1thout hve
Some learning exercises can be conducted enurely �n compu�
ate dis_secuons, metabolic
animals or even mannequins. Computer programs can sunu�
slffi�lauons can _ �e
functions, drug responses, and so on. Th_e re�lism ?f these _
display telev1S1onincreased by use of sophisticated interactive videodiscs, which
.
quality images on computer monitors.
s1IDulate
.
Dr. J.Walker of the University ofTexas uses �ompute!s to
nsive c_ompu�ers �ubstitute
physiological responses for medical stud;nts. �wo mexpe
uon, di�esttve �ystem,
for experiments that demonstrate a dog s cardiovascular regula
a Ptg descnbes two
Guine
and drug responses. A recent article entitled The Electronic
specific examples:

(4) Comp uter Simulations

During the cardiovascular experiment . . . one computer screen dis� la� s a
chart chat tracks blood pressure, heart rate, cardiac output, and �imtlar
information, updated every three seconds; the other scre�n provides a
continuous reading of the most vital data. If a st1:1dent wished to �ee the
effects of the drug epinephrine - a standard medical scho_ol expe�imen�
- he presses a key marked E. Immediately the screen registers a Jump m
blood pressure and heart rate.
Another standard experiment involves slit_ting open _ a dog's thro�t and .
pinching off the arteries. A student can simulate this o� �alker s machme
by pressing theO key: immediately the blood p�essure mdicators nse, the
cardiac output drops, and some lucky dog lives. 1
A wide variety of such computer simulations is now available. 14
(5) Other Procedures or Syste��
.
.
.
.
Other alternatives to tradmonal educational uses _of ammals u�clude replacmg
dogs with videotapes to demonstrate the effects of poisons to vetermary students;
55

· E D U C A T I ON ·
having two or more anatomy students dissect the same specimen or use prosections as
demonstrations; and stipulating that adequately trained supervisors oversee students
working on live animals. Finally, the potential for the use of neomorts in medical
education should not be overlooked.
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Discussion
Educators can have a profound effect on the replacement, reducti
on, and
refinem �nt of educational uses of animals. In order to develop
and implement
alternanve�, educators need _the proper motivation, the support of
their colleagues,
and financial and academic mcentives.
Scientists recognize the importance of academic incentives in develop
ing
educational alternatives, as this observation on development of
computer-based
simulators indicates:
In the long run, the most serious problem to developing these simulators
may :well_ be t�e lack of professional academic rewards for faculty members
workmg_ m this area. Promotion, tenure, and sal ary increments are awarded
predommantl y for productivity in the research laboratory, not for efforts to
develop innovative teaching techniques and materials.With essentially no
external grant support for computer-based education activities and with few
ref�reed high-quality journals i n which to publish, two of the measures by
which !ewards are apportioned are not available to developers of novel
educational software. This is a particular problem for junior faculty
membe�s, who often must devote their major efforts to climbing the
academic ladder.Computer-b as ed education seemingly fails to meet the
perception of an academically valid and credible enterprise. 15
A �though lack of £'.uncling may impede the development of alternatives in some
cases, It may actually dictate the adoption of non-animal methods in others. For
example, the ex-'?ense of procuring and housing dogs in medical schools may force
these schools to lffiplement computer programs instead.
Mo_ney, therefore_, is not all that's needed to foster widespread application of the
alternatives approach m education.Concerned instructors educational
administrators, funding agencies, students, and parents �ust be involved as well.
B!-1t no aJ?OUnt of effort will succeed unless the existing alternatives have merits
.
n
th�u
own nght. Does each alternative get the job done as well as or better than
�
Its ammal-related counterpart? If not, is each alternative still adequate?Educators
should clearly spell out the goals of their animal projects and determine whether or
not alternatives meet those goals.
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General Discussion
PROGRESS IN IMPLEMENTING the alternatives approach has been encouraging,
especially in light of the modest investment of money and effort. In to�city testing,
the first generation of alternative screening tests i_s being develop�d, val1date1,
and implemented.In biomedical research, invesngators ar � applymg alte!nanve
techniques to answer questions in diverse fields. In ed�cat1on, tech� olog1cal
innovation is yielding new alu:rnatives, such as robot-like mannequms and
computer simulators.
.
.
Much of this progress has occurred withi? the !ast ten y�ars, _as the �nlffial-:-nghts
movement has infused the search for alternatives with an ethical lffiperative. Pnor to
this, alternatives were pursued primarily for economic, public health: and scientific
reasons but rarely as a reflection of a sense of moral duty or compassion.Even today,
when specific alternatives are introduced to the scientific community i? research
reports, concern for animals is not necessarily cited as a �eason for theu de�elopment
or possible implementation. Nevertheless, the introduction of new alternatives, for
whatever reason, is still good news.
.
The most exciting alternatives in the areas of research and testing are based
on
_
the development of techniques such as tissue cult�e and co1;Ilputer 1:Ilodehng. Such
_
breakthroughs in technique have been extremely lffiportant m the history of sc� ence,
as Rowan' has emphasized. Technical innovations are used to answer old questions
and address new ones. A historical example is the application of tissue culture to the
prevention of polio. The developmen� of a J?olio va�cine r �quir�d that large amounts
of polio virus be readily available. This was impractical usmg mice an� monkeys,
which were used extensively in polio research.Enders and coworkers d1�covered that
the virus could be cultivated in vitro. This paved the way for Salk, Sabm, and others
to develop effective vaccines. A testament to the importance of the tiss_ue-culture
work in combating polio is thatEnders and coworkers, not Salk or Sahm, were
awarded the Nobel Prize for their polio research!
Some new techniques are not alternatives i? themselves _ b_u� �an, noneth�less,
decrease reliance on laboratory animals by creatmg new poss1bd1t1es for _ stud�mg
humans without recourse to questionable animal models. An example 1s posmon
emission tomography, discussed earlier in relation to human studies of
Parkinson's disease.
Techniques such as positron emission tomography, which decrease reliance on
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a.i:iimal �odels by facilitat�ng the direct study of humans, are sorely needed in
b1�medical research.Consider the remarks of Stephen Suomi, himself an advocate of
animal models:

results widely. 6
We have seen that poor and inhumane animal tests persist despite their faults.
As Sharpe noted, "we cannot delegate our responsibilities onto other animals, who
only reward us with illusions of safety. "7 The remedy for this sorry state of affairs in
toxicity testing is not only better tests, especially alternative tests, but also the
realization that the proper me asure of man is man. The U nited States should
consider adopting a post-marketing surveillance scheme patterned after the one used
in Britain. Early detection of problems with new products in actual use should be an
essential component of safety programs. This was recommended by a 1977European
convention on drug monitoring. The scientists in attendance concluded, in part:

The primary rationale for creating most animal models lies not so much in
any obvious and impressive strengths of such models as it lies in the
problems inherent in conducting research with humans as subjects. 2
The primary pro_blem in conducting research on humans is avoiding undue risk or
harm to the subJects.Consequently, new, powerful techniques that are relatively
harmless should be eagerly embraced by animal modelers.
Biomedical research is not the only area of laboratory animal use that has
�enefited from the application of �ew techniques. A�ternatiye techniques, especially
tissu�-c�lture and c_oI?-pute_r model �ng, are transformmg toxicology from an empirical
exercise mto a predic�ive science._ Tissue-culture techniques can not only determine
whether or not chemicals are toxic but also uncover how toxic chemicals exert their
effects. Mo�e!ing can help identify the structural features of chemicals that are likely
to cause toxicity. �urrent method_ s treat each new chemical as a complete unknown
and use whole ammals to determme whether or not a substance is toxic.
The need for a transformat� on in toxicology was forcefully underscored byNobel
Laureate Joshua Lederberg, president of Rockefeller University:

Only by the careful study of medicines in every day use can greatest
benefits be obtained from their administration, the untoward rare potential
dis as ter recognised at the earliest possible moment, and the ill effec ts
minimised. Absolute safety is unattainable and its pursuit, regardless of
other considerations, is achieving more harm than good [emphasis added]. 8

To a substantial degree, our continued need for animals in testing is a function
of our ignorance rather than our knowledge.4 In 1972, Nobel Laureate Sir Peter
Medawar predicted that the use of laboratory animals on its then-current scale would
dec�ease � biomed �cal knowledge increased. This should hold especially for toxicity
testmg, given that its goals and methods are much more limited than those
pertaining to research.
Toxicity_ testing do�s comprise a diverse array of tests. The replacement of all of
_
these tests wtth alternative techmques will take a long time. In the meantime
toxicologists s�10uld expl?it existing alternatives to the fullest extent. For ex�ple, if
a co�prehensive evaluation of a new chemical requires both alternative tests and
�.ra1��ional tests, t�e former should be conducted first; in this manner, chemicals that
fatl the alternatives tests need not be tested further on animals.
Another w �y of reducing animal use in toxicity testing is to make results of
these tests public. Many manufacturers of drugs, cosmetics, pesticides, and other
compounds make extensive use of animals not only in toxicity testing but also in
product development. The_ results of these investigations are sometimes regarded as
trade secrets; thus, com�etu:�g companies may be inadvertently investigating the
same co �poun�s, resulung m _a was �e o[ animals. Although competition among
companies requues that t�ese �nvest�gattons be kept confidential to some degree,
such secrecy exacts a t?I
I m �imal ltfe and suffering. A compromise solution would
be to requue compames to divulge the results of their investigations after a
specified time.)
Some comp�nies are taking steps to avoid unintentional repetition of toxicity
tests..Th�Chemical Industry Institute ofToxicology, for example, earmarks
contnbutions from member companies for toxicological testing and distributes the

Future progress on alternatives will depend, in part, on the extent to which the
alternatives approach is embraced by biomedical scientists.While a few of these
scientists view the approach favorably, the response of others has been lukewarm. 9
Researchers seldom target their work toward alternatives as ends in themselves. Some
dismiss the approach altogether. 0• Recent progress on alternatives suggests that
these naysayers are fighting a losing battle.
Several factors probably contribute to the scientific community's resistance to the
alternatives approach. First, alternatives tend to be viewed in the narrow sense of
replacements. Because replacements for some types of laboratory animal procedures
will take many years to develop, this narrow view of alternatives engenders
unnecessary pessimism. Adoption of the broader definition of alternatives as
reductions and refinements as well as replacements should make the alternatives
approach seem less quixotic.
A second re ason for scientists' resistance to alternatives may be that alternatives
are promoted by (among others) the opponents of animal research, namely,
anti-vivisectionists. Animal researchers may not want to be seen as giving in to their
opponents or they may view anti-vivisectionists as zealously promoting alternatives
that are ineffective in order to save animals.
A third and related reason is that advocates for alternatives may be viewed as
irrational and anti-research. However, the target of these advocates is not research in
· general, but animal research. G iven the extent to which groups advocating
alternatives are funding research on alternatives, the anti-research charge seems to be
a smoke screen.
Fourth, researchers who were trained to use animals may be hesitant to learn
new techniques.
Perhaps the most cynical suggestion for the resistance to alternatives is that
alternatives pose a threat to the multi-billion-dollar industry of animal research.
Thousands of people make a living from animal research. Scientists do so by
conducting the research; veterinarians by administering to research animals; dealers
by selling animals; and manufacturers by supplying cages, food, antibiotics, etc.
Research institutions also profit by receiving a hefty percentage of the money
awarded to their individual researchers. Some of these people or institutions
undoubtedly would rather maintain the status quo than make the adjustment to an
alternatives-based research industry.
Some money is given specifically for alternatives research.Though the amount is
small compared to funding for animal research, it may lure some animal researchers
into alternatives. T.D. Overcast and B.D. Sales claim that some animal researchers
are pursuing alternatives for another reason, namely, to protect themselves from the
impact of future regulations on animal research. 12 However, this claim may have
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I think the testin� of substances could be greatly improved above all by
better unders tandmg of the mechanisms by which these substances work.
The o? e or two o� thre� hundred millions of dollars a year that we're now
SJ?endmg on routme �mmal _tes�s are almost all worthless from the point of
view of standard-settmg. It ts stmply not possible with all the animals in
the world to _go through new chemicals in the blind way that we have at
the present ttme, and reach credible conclusions about the hazards to
human health. 3
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been made more for its alarmist effect on regulators and its portrayal of animal
researchers as beleaguered than for its reflection of a realistic trend.
Of cou�se, it would be foolish to suggest that all biomedical scientists oppose
the alternatives _ approach and all have questionable motives, even those who
pursue alternat1ves.
Whatever the motivations and beliefs of researchers the case for alternatives
ust
�lti1!1ately b� judged on its own merits. There is a 'surprising amount of
�
h1st�ncal mform �t10 � on which to base this judgment. In the following analysis,
co�s1der alternatives m the narrow sense of techniques that avoid the use of intact
�mmals altogether. A ctually, this is too narrow a definition because we want to
mclude the use of "less sentient organisms" (invertebrates, microorganisms, plants,
�nd ve_rtebrate embryos) as an alternative technique. And, of course, we are also
mclu_dmg hu�an and in vitro studies, mathematical modeling, and
phys1cal-chem1cal techniques.
. Most of the�e techniques have existed for decades, although they have not been
d1scuss_ed much m the c�>ntext of alternatives until the last ten years or so.
So�et1mes, these techmques were used in projects that could have been conducted
on mt�ct vertebrate animals; today, we' cl categorize these as alternative projects. In
other !�s_tances, "alternative" techniques were used in projects that were beyond the
capabdmes of vertebrate studies.
Nobel Prize awards in medicine or physiology can be used as an index of the
.
Importance of alternative techniques in the history of biomedical research. These
award� ar� generally believed to recognize research "of the highest calibre, the most
end�rmg mfluence, and the most importance to biomedical science" according to the
National A cademy of Sciences (NA S). 13
A wards that we_re made fo� rese�rch whose success depended wholly or primarily
on alternative techmqu�s wer � 1d�nt1fied. The remaining awards were for projects
that were successful owmg prtmardy to in vivo studies of vertebrates labeled
non-alternative techniques. Sufficient information was available to c'lassify all but
two awards. AI_though most of the other seventy-four awards were readily classified,
some proved difficult. These _w_ere generally assigned to the non-alternative category.
Wh�n th� same award "'.'as dlVlded among two or more projects, the award was
class1�ed �n the alternauve categ?ry as long as at least one project depended wholly
or pnmardy on alternative techmques.

studies in biomedical research. For example, many animal researchers were skeptical
of tissue-culture systems in the early days of this technique's existence. According to
NAS, if not for this skepticism, tissue culture "might14 have been used to discover
many of the vitamins, amino acids, and hormones." Tissue culture could have been
used to discover the hormone insulin, for instance.Even human studies could have
yielded this discovery. Yet the researchers who discovered insulin used traditional in
vivo methods, with dogs. They were awarded the Nobel Prize in 1923. This
by-product of tradition is often regarded as a triumph of animal rese arch, yet other
techniques could have done the job.
Twentieth century Nobel Prizes in medicine or physiology were analyzed from a
somewhat different perspective by NAS, which focused on the types of organisms
used in the award-winning research, instead of on techniques. The results were
compared to funding patterns of NIH to assess whether funds were allocated among
types of organisms according to their representation in award-winning research
(which presumably is some indication of the relative value of these organisms
in biomedicine).
NAS concluded that research on mammals was being overfunded in relation to
its representation in the Nobel awards and in other outstanding research:

About fifty (or two-thirds) of the Nobel Prizes were awarded to projects using
lternattve
techniques (see A ppendix A ). This finding clearly documents the
�

1mportanc� of t�ese techniques in the history of biomedicine. The techniques
advocated m this report have been used to conduct first-rate biomedical research and
can contmue to do so.
Those projects that used alternative techniques were further classified as to
whether the projects themselves can be considered alternatives to research on whole
�erteb_ rates or "." hether the projects investigated topics that could not have been
mvesugated usmg "."hole v�rtebrates. Although there were several equivocal cases, the
fifty aw_ards for proJects usmg alternative techniques fell about equally in both
categones (twe�ty-four and twenty-six, respectively).
The �echmques advocated in this report have been the cornerstone of some of
the t�ent1eth century's most significant biomedical research. In some cases, they have
subsmu_ted for the use of vertebrates; in other cases, they have added to our
b1omed1cal kn?wled�e in ways that were not feasible using vertebrates.
T_wo cons �derat1ons are important in interpreting the results of the Nobel
analysis :One 1s that most of the award-winning projects were conducted before the
alternat1ve� appr?ac� was �rst articulated ( 1959). This increases expectations of what
�an be achieved if b10med1cal researchers actively pursue alternatives as ends
m themselves.
The sec�nd consi?erati�n is that more awards would have gone to projects that
used alternat1ve techmques if not for the traditional emphasis on in vivo vertebrate
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Considering the great strides in our understanding of biology and medicine
that have resulted from the study of microorganisms, invertebrates, and
lower vertebrates, the proportion of NIH resources that supports research in
this area may be small in comparison to the resources dedicated to resear ch
with mammals. 1 )
This suggested misapplication of funds may result from what was described
earlier as the high fidelity fallacy - that mammals are of exceptionally high fidelity as
models of humans and therefore should be used as often as possible. NAS
recommended resisting this perspective:
Proposals for the study of invertebrates, lower vertebrates, microorganisms,
cell- and tissue-culture systems, or mathematical approaches should be
regarded as having the same potential relevance to biomedical research as
proposals for work on systems that are phylogenetically more closely related
to humans. Support should be given to good resear ch without taxonomic or
phylogenetic bias on the part of the sponsor and should include
comparative and phylogenetic studies. 16
NAS's recommendation is directed at NIH funding patterns such as the one
depicted in Figure 1. The figure displays information for 1983, the most recent year
for which information is available. Information from previous years (1980-1982)
shows similar trends. Note that research on vertebrate animals, especially mammals,
was the highest funded category. It exceeded the combined funding for resear ch
using in vitro techniques, mathematical modeling, and less sentient organisms
(invertebrates, microorganisms, and plants). Funding for research on nonhuman
mammals alone exceeded funding for human research, despite the fact that the
mission of NIH is to protect human health.
Funding decisions are influenced to a certain extent by the interests and
perspectives of the scientific community. Hence, alternatives research undoubtedly
would be a higher priority if scientists supported the alternatives approach. In issues
that involve the use of animals in research, such as alternatives, scientists are often
portrayed as being engaged in polarized battles with anti-vivisectionists. In a sense,
we are all anti-vivisectionists because none of us wants animals to have to suffer or
die in laboratories. The alternatives approach can provide a common ground for both
researchers and animal advocates to demonstrate their humane concern. This view is
reflected in the policy of The Humane Society of the United States on the use of
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FIGURE 1
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laboratory animals (see Appendix B).
Enthusiastic support for the alternatives approach, not only by researchers and
animal-rights advocates but also by funding agencies, regulatory agencies, educators,
and the general public, will hasten the day when laboratory animals are spared from
their regrettable plight.
The alternatives approach is part of a more inclusive approach toward animal
research that is characterized by concern for animals. This humane concern can be
expressed in various ways in addition to seeking replacement, reduction, and
refinement. For example, researchers contemplating the use of animals should
determine, first, whether their topic is worth investigating and, second, whether
their research would involve unnecessary duplication. Such duplication can be
reduced by searching through computerized bibliographies of published research
reports and by determining whether relevant research published in foreign languages
has been translated. The JohnCrerar library at the U niversity ofChicago is a
clearinghouse for such translations. Third, researchers should determine whether the
chosen animal species is the best (or at least an adequate) subject of study.Research
conducted on poor or invalid "animal models" is a waste of animals and effort.
Albert Schweitzer was a prominent exponent of this perspective. He wrote:
Those who carry out scientific experiments with animals, in order to apply
the knowledge gained to the alleviation of human ills, should never
reassure themselves with the generality that their cruel acts serve a
useful purpose.
In each individual case they must ask themselves whether there is a real
necessity for imposing such a sacrifice upon a living creature. They must try
to reduce suffering insofar as they are able. 17

Human and
Nonhuman
Vertebrates
(13 % )

Humans (24%)

TOTAL: $3,234,737,694

1. Distribution of support from the National Institutes of Health (NIH) for research on
various organisms
_
�unng 1983. ��g_ures are for excramu�al research (i.e., research not conducted at NIH) only.
_
Miscellaneous mcludes proJects
on mvertebrates in combination with various other organisms.

SOURCE:

Adapted f�om Table 4-3 in National Academy of Sciences, Models for Biomedical R
ese(lrr;h (Washington
D.C.: Nauonal Academy Press, 1985).
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A humane approach to research goes beyond asking questions about specific
projects. It calls for a reappraisal of the entire biomedical research paradigm, which
emphasizes the development of treatments for people who are already sick. The
application of this paradigm has exacted a heavy toll in animal suffering and death.
Many people have cogently argued that this paradigm is misguided even from the
point of view of human health. 18 Human health would be better served if prevention
were emphasized over treatment. A biomedical research program that emphasized
prevention would shift research away from animal studies and direct it more toward
screening programs and alternative techniques, especially epidemiological and clinical
studies on humans.
The case for prevention over treatment was recently made by JohnCairns of
Harvard U niversity's School of Public Health 19 in a discussion of cancer research.
About one hundred different kinds of human cancer are recognized. Because these
cancers have their own characteristics, each should be considered as if it were a
separate disease. U nfortunately, fewer than fifty percent of cancer patients can be
cured by surgery. Supplementary treatments involve administration of hormones,
radiation, and chemotherapy. The success rate of these supplementary treatments has
been disappointing; they avert only about two to three percent of the 400,000 deaths
from cancer each year in the U .S., and they can have serious, sometimes lethal, side
effects.Cancer specialist Dr. H. Bush notes that some treatments are so physically
and psychologically degrading that some patients wonder whether the treatment is
more disabling than the disease. 20 Although some cancers can be effectively treated,
these are not the major forms of cancer.
Cairns contrasted the disappointments with our national cancer policy, which
emphasizes treatment, with a potential policy that emphasizes screening and
prevention. He wrote:
Thanks to the cigarette, the U . S. now suffers a completely unnecessary
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additional 100,000 deaths per year from lung cancer. These numbers dwarf
the 5,�00 to 10,000 lives that are being saved by chemotherapy. Some
countnes have banned all tobacco advertising, and this has had an almost
instant effect on tobacco sales. The failure of the U.S. Government to take
such a step far outweighs all the advances made in the treatment of cancer
since the advent of modern surgery.
Cairns also turned to the history of modern medicine to support his case for a
prevention-based cancer policy:
None of the important causes of death has been primarily controlled by
treatment. The death rates from malaria, cholera, typhus, tuberculosis,
scurvy, pellagra, and the other scourges of the past have dwindled in the
U.S. _m ainly because humankind has learned how to prevent these diseases,
not sunply because they can be treated. There are many grounds for
believing that when any major disease is tackled on a national scale the
chief effort should be to prevent its occurrence. To put most of the 'effort
into treatment is to deny all precedent .
T�e so-called w ar n. cancer is just one example of limited gains resulting from
�
anunal research. Mtlhons of dollars have been spent searching for elusive cures to
various other diseases, while suppon for diagnostic programs and preventive me asures
pales in comparison. Humans as well as animals are the losers.
While defenders of animal research are quick to point out the successes of
animal research, they fail to add that the advancement of medicine and human
health has been hindered by an overemphasis on this form of research. In addition
to c�ncer researc_h , examples include research on cocaine abuse, 21 depression, 2• 3 and
cardiovascular diseases. 24
Our i�ated hopes [�r animal-based treatments are undoubtedly fueled by
rese��hers self-aggran�mng pronouncements and the resulting media hype. As
physman Bush noted with respect to cancer research, "Cures seem to happen more in
press releases than in patients."2) Dr. P . Goldhaber, the dean at Harvard's School of
Dental Medicine, argued that researchers are "boasting prematurely about the
advances and triumphs" of their work and are "extrapolating prematurely
from . . . an�al studies to humans. "26 He cited the fields of dentistry, cancer and
tuberculosis research to support his conclusion .
An emphasis on cure detracts not only from prevention but also from the
physical and psychological care of the sick. Bush wrote:
2

2

A reorientation of research tow ard prevention need not entail a total
abandonment of research aimed at treatment. However, treatment-based research
should take advantage of new applications of alternative techniques in a wide variety
of areas, including cancer30 and AIDS.
The paradigm shift from treatment to prevention can be translated into our
everyday lives . On the basis of numerous human studies, physician J. Scharffenberg
concluded that personal health and salvation from disease are largely a matter of
personal choice. He described a life-style that promotes health and dramatically
reduces the risk of disease. It includes, among other things ,
a good diet of fruits, whole grains, nuts, and vegetables while avoiding the
meat and high animal fat products and eggs, adequate sleep, good exercise
in the open air, abstinence from harmful things such as tobacco, alcohol,
coffee, tea, and other drugs, drinking plenty of water, moderation in all
things including the amount of food eaten . . . . 31
Taking greater personal responsibility for our own health would lessen our
reliance on animal-based treatments. In the event that we become sick, we should
think twice before taking drugs that were developed or tested on animals. Are
treatments available that are not animal-based? Will rest and relaxation be sufficient
for recovery?
In a similar vein, we should keep laboratory animals in mind when shopping.
First, we should buy products whose development and testing did not involve
animals. A list of companies that sell "cruelty-free" cosmetics and toiletries is
available from The Humane Society of the United States. Second, we should avoid
buying household products that are "new and improved," as these modifications
probably necessitated further animal testing.

As many cancer clinicians have found, a diagnosis of cancer can so
demoralize a patient that the debilitating effects are far worse than the
early physical effects of the disease . . . .
It is time that more of the research doll ars now devoted to cure be diverted
to finding new and more humane ways of caring that will make a can�er
patient 's �emaining years happier, more comfortable, and more productive.
My expenence suggests that in the patient's eyes good care aimed at
improving the quality of life may be just as imponant as cure. 27
There are signs that our national cancer policy is beginning to reflect the
importance of prevention . 28 The National Cancer Institute is financing the
establishment ?f "cancer prevention research units" around the country to discover
c�cer-prev�ntmg strateties, including diet ary changes . Instead of using laboratory
an11I.1als, t�is research will test "likely cancer preventives in the most persuasive way
possible - m the real world, over periods of years , on thousands of healthy
human beings ."29
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IX

Conclusions
RECENT P
ROGRESS in the development and implementation of alternatives is
encouraging, especially given the relatively small investment of money and effort.
Technical advances are already being translated into tangible results, not only in
terms of animal welfare, but also in public health and cost savings. The public's
concern for animals is partly responsible for this progress.
The application of the alternatives approach is still far from the ultimate
goal of eliminating the use of laboratory animals.What is needed is a more
concerted effort among researchers, toxicologists, educators, funding agencies, and
regulatory agencies.
Whether or not such an effort is made will depend in large part on public
enthusiasm. As a fust step, people should familiarize themselves with the alternatives
approach. This will enable them to recognize wild exaggerations made by
animal-research defenders; for example, that biomedical research would collapse
without the traditional use of animals or that the only alternative to using animals is
to use ourselves.
Researchers probably would take alternatives more seriously if more people
became knowledgeable on the topic. Researchers and laypersons eventually may share
the goal of replacing animals in laboratories. If this goal is met, our mental image of
biomedical research as an animal huddled in a cage will be replaced by more
heartening images.
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Nobel Prizes in Medicine or Physiology A warded for ResearchWhose Success
Depended Primarily orWholly on Alternative Techniques.
YEAR

WINNER

TECHNIQUE1

TOPIC

1902

R. Ross

LSO

1903

N. Finsen

IV

1907

C. Laveran

H

1908
1909

E . Metchnikoff
T . Kocher

LSO, IV

Discovered insect vector of
malaria and other aspects of this
disease
Treatment of diseases, especially
lupus melgaries with concentrated
light radiation
Role of protozoa in causing
diseases
Immunity
Physiology, pathology, and
surgery of the thyroid gland
Protein chemistry of cells,
including nucleic substances
Dioptrics of the eye
Physiology and pathology of the
vestibular apparatus

H

1910

A. Kosse!

V
I

1911
1914

A . Gullstrand
R. Barany

H, MM
H

19 15-1918, 1921, 1925: No Prizes Awarded
1927
J.Wagner-Jauregg H

H

1928
1930

C. Nicolle
K. Landsteiner

IV

1931

0.Warburg

V
I

1933

T. Morgan

LSO or V
I

1935

H . Spemann

LSO

1937

I
A. von Szent-Gyorgyi V

1940-1942: No Prizes A warded
V
I
J.Erlanger
1944
H. Gasser
V
I
A . Fleming
1945
E. Chain
H. Florey
LSO
H. Muller
1946
LSO
P. Muller
1948
1949

E. Moniz2

Malaria inoculation in treatment
of dementia paralytica
Work on typhus
Discovery of the human blood
groups
Nature and mode of action of the
respiratory enzyme in yeast
Role of the chromosome in
heredity (fruit flies)
Organizer effect in amphibian
embryonic development
Biological combustion process,
with special reference to vitamin
C and the catalysis of fumaric acid
Differentiated functions of single
nerve fibers
Penicillin and its curative effect
on various infectious diseases
Production of mutations by X ray
Efficiency of DDT as a contact
poison against several arthropods
Therapeutic value of a
psycho-surgical procedure in
certain psychoses

H
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YEAR

WINNER

TECHNIQUE'

TOPIC

YEAR

WINNER

TECHNIQUE'

TOPIC

1951
1953

M . Theiler
H. Krebs
F. Lipmann

IV
IV

1972

Chemical structure of antibodies

J. Enders

IV

R. Poner
G. Edelman
K. von Frisch
K. Lorenz
N. Tinbergen
A. Claude
G. Palade
C. de Duve
R. Dulbecco
D . Baltimore
H . Temin
B. Blumberg2

IV
IV

1954

Vaccine against yellow fever
Citric acid cycle and coenzyme A
and its role in intermediary
metabolism
Cultivation of poliomyelitis
viruses in tissue culture

1955
1956
1958

1959
1962

1963
1964
1965
1966
1967
1968
1969
1970
1971

F. Robbins
T. Weller
H. Theorell

A. Cournand
W. Forssmann
D. Richards
G. Beadle
E. Tatum
J. Lederberg

IV

H
LSO
LSO

S. Ochoa
A. Kornberg
F. Crick
J. Watson
M. Wilkins

IV

J.

IV

Eccles
A. Hodgkin
A. Huxley
K. Bloch
F. Lynen

IV

LSO, IV

F. Jacob
A . Lwoff
J. Monod
C. Huggins2

H

G. Wald2
K. Hartline
M. Nirenberg
R. Holley
H. Khorana
M. Delbruck
A. Hershey
S. Luria
B. Katz2

IV
LSO, H
IV
IV
IV
LSO/IV
LSO/IV
LSO/IV
IV

E. Sutherland, Jr.

LSO

IV

70

Nature and mode of action of
oxidizing enzymes
Heart catheterization and
pathological changes in the
circulatory system
Genes regulate chemical processes
(bread mold)
Genetic recombination and the
organization of the genetic
apparatus of bacteria
Mechanisms of the biological
synthesis of RNA and DNA
Molecular structure of nucleic
acids and its significance for the
transfer of information in living
material
Ionic involvement in the
excitation and inhibition of nerve
cell membranes
Mechanism and regulation of
cholesterol and fatty acid
metabolism
Genes that control activity of
other genes
Hormonal treatment for cancer of
prostate and breast
Chemical and physiological visual
process in the eye
Interpretation of the genetic code
and its function in protein
synthesis
Replication mechanism and
genetic structure of bacterial
viruses
Transmitters in nerve terminals
and the mechanism of their
storage, release, and activation
Mechanisms of the action of
hormones

1973
1974
1975
1976

IV
IV
IV
IV
IV
IV
H

R. Yalow

IV

R. Guillemin
A. Schally
W. Arber
H. Smith
D . Nathans
A. Cormack
G. Hounsfield

Mi

1981

R. Sperry2

H

1982

S. Bergstrom
B . Samuelsson
J. Vane
B. McClintock

IV, PC
IV, H
IV
LSO

C. Milstein
G. Kohler 3
M. Brown
J. Goldstein

IV

1977

1978
1979

1983
1984
1985

Organization and elicitation of
individual and social behavior
patterns
Structural and functional
organization of the cell

Mi
Mi
Mi

Interaction between tumor viruses
and the genetic material of cells
New mechanism for the origin
and dissemination of infectious
disease
Development of radioimmunoassay and the principles
underlying it
Hypothalamic hormones
Discovery and application of
restriction enzymes

LSO/IV
LSO/IV
LSO/IV

Development of the X ray
diagnostic technique, computerassisted tomography
Functions of the cerebral
hemispheres
Biochemistry and physiology
of prostaglandins

MM, H
MM, H

Discovery of mobile genetic
elements (in corn)
Development of a technique for
monoclonal antibody formation
Cholesterol biochemistry and
familial hypercholesterolemia

IV, H

IH = Human Studies, IV = In Vitro Studies, MM = Mathematical Modeling, PC = Physicochemical
Techniques, LSO = Studies of Less Sentient Organisms (Vertebrate Embryos, Invertebrates,
Microorganisms , and Plants), and Mi = Miscellaneous.
2Award shared with researcher(s) who used non-alternative methods.
lAward shared with N. Jerne for his theoretical conuibution.
SOURCES:
York:
Sourkes, T.L. Nobel Pn'ze Winners in Medicine and Physiology, 1901-1965 (New
1966).
chuman,
Abelard-S
Science. 1966-1985 . Various articles on Nobel Prize winners.
Milstein, and
Garfield, E. "The 1984 Nobel Prize in Medicine Is Awarded to Niels K. Jerne, Cesar
1 1 November 1985).
Georges J.F. Kohler for Their Conuibutions to Immunology," Cu"ent Contents (
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Animals in Biomedical Research and Testing, from Statement of Policy,
The Humane Society of the United States ( 1984).
The Humane Society of the United States recognizes that benefit for both
animals and mankind has been achieved through some scientific research and testing
on animals, but that the advancement of medicine and human health has also been
hindered by an overemphasis on such animal research. It recognizes that uses of
animals in biomedical research, safety testing, and other programs are many and
varied, and that this research and testing is not likely to end in the
immediate future.
While some of the animals used in research and testing are subjected to
procedures that result in only momentary discomfort, The HSUS believes that
millions of laboratory animals do suffer severely and needlessly in painful
experiments, resulting from exposure to noxious substances and pathogenic
organisms, or from cruelty, carelessness, ignorance, and indifference. The HSUS also
contends that toxicity testing on live animals, as now required by government
agencies to test the safety of serums, drugs, cosmetics, and other chemicals, is often
unreliable, inaccurate, and unnecessary and should be replaced as soon as possible by
new methods not involving animal suffering.Existing measures intended to ensure
humane treatment, including the AnimalWelfare Act and its enforcement, have
proven inadequate. The AnimalWelfare Act should be strictly enforced. Coverage
should be expanded to include all vertebrates used, protect animals undergoing the
actual research and experimental process, and require prohibition of specific painful
invasive procedures.
The HSUS believes that scientists and facilities using experimental animals
should be held strictly accountable for their care and use and should keep animals in
a manner fulfilling both physical and behavioral needs. Experiments should be
rigorously planned, with proper statistical design, so as to minimize the number of
animals necessary to be used to achieve reliable results and, through the
administration of anesthesia and analgesics and other appropriate medication and
veterinary care required, to preclude animal suffering. The HSUS believes that
government agencies and relevant professional organizations should encourage and
actively support efforts to eliminate animal suffering in the laboratory.
Therefore, The HSUS strongly advocates the development and application of
alternative methods of research and testing, which could reduce the number of
animals required, refine existing techniques and procedures so as to minimize the
level of stress endured by an animal, and replace the use of laboratory animals.
Refinement and reduction are interim steps toward the ultimate goal of complete
replacement of animals in biomedical research and product testing.
Therefore, it is the policy of The Humane Society of the United States to use
every means in its power to reduce and end the suffering of animals in biomedical
research and testing laboratories by advocating the attitudes and approaches set forth
in this statement.
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Acute toxicity: Toxic effects produced by a single dose of a compound. Dose is often
large relative to the body weight of the animal. The test usually is limited to one to
two weeks in duration.
Analgesic: Substance used to induce insensitivity to pain without loss
of consciousness.
Anatomy: The structure of an organism.
o

Animal model: A particular type of animal used as a surrogate fr humans in a
research project. The animal is defined by its species and perhaps additional features,
such as genetic uniformity.
Assay: A procedure or system used to determine the potency or concentration of
a compound.
Bioassay: A procedure or system used to determine the potency or concentration of a
compound by its effect upon animals, isolated tissues, or microorganisms, as
compared with a standard preparation.
Biological: Biologically active substances such as hormones, antibodies, vaccines,
and antiserum.
Biopsy: A specimen of tissue obtained from living patients for diagnostic
examination; or the process of removing this tissue.
Carcinogen: Any agent that produces cancer.
Carcinogenic: Causing cancer.
Cardiopulmonary resuscitation: Restoration of breathing and heartbeat after
apparent death.
Chronic (long-term) : Multiple doses or continual exposure in. feed, water, or
.
atmosphere to determine safety thresholds and long-term toxic effects. Duration of
exposure can be two years or longer.
Chorioallantoic membrane: A membrane found in the avian egg.
Clinical: Relating to observations of a patient or the course of his or her symptoms;
often used in contradistinction to experimental, as in experimental study of animals
intentionally made sick.
Conjunctiva: The membrane that lines the inner surface of the eyelids and connects
to the forepart of the eyeball.
Congenital: Existing at birth; referring to certain mental or physical traits or
peculiarities, malformations, etc.
Cornea: The transparent, front part of the eye that covers the iris and pupil.
Dissection: The act of cutting apart the tissues of the body in the study of anatomy
(or in a surgical operation).
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Enzyme: A protein secreted by cells that acts as a catalyst to induce chemical changes
in other substances.
Epidemiology: The study of the prevalence and spread of disease in a community,
especially infectious and epidemic diseases.
Genetic: Referring to the hereditary (or genetic) material .
Hormone: A chemical substance formed in one organ or part of the body and carried
in the blood to another organ or part. Hormones can alter functional activity, and
sometimes even the structure, of one or more organs.
Immune system: The body's system that is involved in combating infectious diseases,
rejecting foreign tissue, and inducing hypersensitivity (allergic reaction) to
specific substances.
Invertebrate: The taxonomic name for multi-cellular animals without backbones; for
example, worms, crayfish , flies , and beetles.
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Ophthalmic: Relating to the eye.
Pathological: Resulting from disease.
Physiology : The study of the normal, vital processes of animals and plants, such
as respiration.
Postmortem: After death, referring to examinations of corpses.
Replication: The act of repeating a process or observati?� ;- in genetics, referring to
the duplication of genetic material that precedes cell d1vts1on.
Spinal reflex: An involuntary movement in response to stimulation to the body's
surface and transmitted to the spinal cord.
Statistics: A discipline that deals with techniques for designing research and for
analyzing and drawing conclusions from the resulting data.

Invasive: Referring to procedures that involve penetrating the body, as in surgery.

Structure /activity relationship (SAR): A mathematical model that relates the
structure of a series of chemicals to their activity, such as toxicity.

In Vitro: In a test tube or other laboratory container; referring to bodily tissue, cells,
or cellular components studied in isolation. See in vivo.

Teratogen: Any agent that induces abnormal development,
p articularly malformations.

In Vivo: In the living body; referring to processes studied in the intact organism , as
opposed to in vitro.

Teratogenic: Causing abnormal development.

Iris: The part of the eye that controls the amount of light hitting the lens; the iris is
variously colored in different individuals .

Toxicity: The state of being toxic or poisonous.
Vertebrate: The taxonomic name for animals with backbones, namely, fishes,
amphibians, reptiles, birds, and mammals.

Median: The middle value in a set of measurements; an 1D50 value is the median
lethal dose.
Metabolism: The sum of the processes by which a particul ar substance is handled
biochemically by the body . .
Microsome: One of the small , spherical vesicles derived from a cell structure (the
endoplasmic reticulum) during isolation of cell-free extracts . It does not exist as such
in the undisrupted cell.
Microsurgery: Surgical procedures performed under the magnification of special
surgical microscopes.
Mutagen: Any agent that induces mutations.
Mutagenic: Causing mutation.
Mutation: A change in the genetic material that is perpetuated in subsequent
divisions of the cell in which it occurs .
Neomort: The body of a recently deceased person.
Nervous system: The body's system involved in transmitting nerve impulses from
receptor organs, such as the eye, to the brain (or spinal cord), where they are
interpreted; this may result in a response that consists of a nerve impulse being
transmitted to an effector, such as the hand.
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